JPH0616689A - De-n-acetyl gm2 - Google Patents

De-n-acetyl gm2

Info

Publication number
JPH0616689A
JPH0616689A JP4173148A JP17314892A JPH0616689A JP H0616689 A JPH0616689 A JP H0616689A JP 4173148 A JP4173148 A JP 4173148A JP 17314892 A JP17314892 A JP 17314892A JP H0616689 A JPH0616689 A JP H0616689A
Authority
JP
Japan
Prior art keywords
compound
group
chcl
acetyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4173148A
Other languages
Japanese (ja)
Inventor
Hideji Fujita
秀司 藤田
Masaaki Numata
昌明 沼田
Mamoru Sugimoto
守 杉本
Kenkichi Tomita
謙吉 冨田
Tomoya Ogawa
智也 小川
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KANTO ISHI PHARMA CO Ltd
Mect Corp
Original Assignee
KANTO ISHI PHARMA CO Ltd
Mect Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KANTO ISHI PHARMA CO Ltd, Mect Corp filed Critical KANTO ISHI PHARMA CO Ltd
Priority to JP4173148A priority Critical patent/JPH0616689A/en
Publication of JPH0616689A publication Critical patent/JPH0616689A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To provide a new compound having antigenicity and useful for the production of a monoclonal antibody to be used in the diagnosis of cancer and melanoma. CONSTITUTION:The de-N-acetyl GM2 of formula I (Ac is acetyl) and its salt. The compound can be produced by reacting a compound of formula II (R is Li; Piv is pivaloyl; Bz is benzoyl) with methylamine in methanol. The compound of formula II is a new compound and obtained e.g. by subjecting a compound of formula III successively to N-phthaloylation and acetylation, reacting with a compound of formula IV (Bn is benzyl), reacting the product with a compound of formula V (Et is ethyl) and then with thioacetic acid, subjecting the product successively to debenzylation and acetylation, reacting with hydrazineacetic acid, reacting the product with trichloroacetonitrile, reacting the obtained compound with a compound of formula VI and finally reacting the product with lithium iodide.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、ガングリオシド類に関
し、さらに詳細には、デ−N-アセチル−GM2に関する。
FIELD OF THE INVENTION The present invention relates to gangliosides, and more particularly to de-N-acetyl-GM 2 .

【0002】[0002]

【従来の技術】近年、シアル酸のN-アセチル基が脱離し
たガングリオシド、すなわちデ−N-アセチルガングリオ
シド類が天然から見出され、ガン関連抗原として注目さ
れている(N. Hanai, et at., J. Biol. Chem., 263, 6
296-6301, 1988; A. E. Manzi,et al., J. Biol. Che
m., 265, 13091-13103, 1990)。箱守らは、天然から得
たGM3 を出発原料として部分的にアミド結合を切断し
てデ−N-アセチルGM3 を半合成しているが、天然に存
在するデ−N-アセチルガングリオシドは微量であるため
原料としてGM3 を多量に使用することができなかっ
た。このような修飾ガングリオシドの発見により、他の
デ−N-アセチルガングリオシド類の生物機能についても
注目されている。本発明者らはデ−N-アセチルGM2
提供を目的として研究を行ってきたが、GM2 は天然界
に微量しか存在しないガングリオシドであり製造原料と
して使用するには適当ではなく、かつ分子内に2個のN-
アセチル基及び1個のアミド結合を有しているので、デ
−N-アセチル−GM2 をGM2 から半合成的に製造するた
めには、これらのアミド結合の切断を選択的に行う必要
があり、製造工程が煩雑である。
2. Description of the Related Art In recent years, gangliosides from which the N-acetyl group of sialic acid has been eliminated, that is, de-N-acetylgangliosides, have been found in nature and have attracted attention as cancer-related antigens (N. Hanai, et at ., J. Biol. Chem., 263, 6
296-6301, 1988; AE Manzi, et al., J. Biol. Che
m., 265, 13091-13103, 1990). Hakomori et al. Semi-synthesize de-N-acetyl GM 3 by partially cleaving the amide bond using GM 3 obtained from nature as a starting material, but the amount of naturally occurring de-N-acetyl ganglioside is very small. Therefore, it was not possible to use a large amount of GM 3 as a raw material. With the discovery of such modified gangliosides, the biological function of other de-N-acetyl gangliosides has been attracting attention. The inventors of the present invention have conducted research for the purpose of providing de-N-acetyl GM 2 , but GM 2 is a ganglioside that is present only in a trace amount in the natural world and is not suitable for use as a raw material for production. Two N- in
Because it has an acetyl group and one amide bond, to produce semi-synthetically de -N- acetyl -GM 2 from GM 2 it is necessary to perform the cutting of these amide bonds selectively Yes, the manufacturing process is complicated.

【0003】[0003]

【発明が解決しようとする課題及び課題を解決するため
の手段】従って本発明は、合成的手法によりデ−N-アセ
チル−GM2 を提供することを目的とする。また、デ−N-
アセチル−GM2 の製造に有用な製造中間体の提供も目的
としている。本発明のデ−N-アセチルGM2 は下記式で
示される。
SUMMARY OF THE INVENTION Accordingly, the object of the present invention is to provide de-N-acetyl-GM 2 by a synthetic method. Also, de-N-
It is also an object to provide a production intermediate useful for the production of acetyl-GM 2 . The de-N-acetyl GM 2 of the present invention is represented by the following formula.

【0004】[0004]

【化6】 [Chemical 6]

【0005】上記化合物の塩も本発明に包含される。例
えば塩基付加塩として、上記化合物のリチウム塩、ナト
リウム塩、カリウム塩、アンモニウム塩等を例示するこ
とができ、酸付加塩としては上記化合物の塩酸塩、硫酸
塩、燐酸塩、リンゴ酸塩、酒石酸塩、シュウ酸塩等を例
示することができる。本発明により、上記のデ−N-アセ
チル−GM2 の製造に有用な製造中間体も提供される。本
発明のデ−N-アセチル−GM2 製造中間体は、下記の一般
式 (II) で示される化合物:
Salts of the above compounds are also included in the present invention. Examples of the base addition salt include lithium salt, sodium salt, potassium salt, ammonium salt and the like of the above compound, and acid addition salt includes hydrochloride, sulfate, phosphate, malate, tartaric acid of the above compound. Examples thereof include salts and oxalates. The present invention also provides a production intermediate useful for producing the above-mentioned de-N-acetyl-GM 2 . The intermediate for producing de-N-acetyl-GM 2 of the present invention is a compound represented by the following general formula (II):

【0006】[0006]

【化7】 [Chemical 7]

【0007】下記の一般式 (III)で示される化合物:A compound represented by the following general formula (III):

【0008】[0008]

【化8】 [Chemical 8]

【0009】下記の一般式 (IV) で示される化合物:A compound represented by the following general formula (IV):

【0010】[0010]

【化9】 [Chemical 9]

【0011】である。上記一般式中、R1 、R4 、R8
はアミノ基又は保護されたアミノ基を示す。保護された
アミノ基としては、アセチル基、フタロイル基、1,2-シ
クロヘキサンジカルボキシルイミド基等のアミノ基の保
護基として当業者に周知の保護基で保護されたアミノ基
を挙げることができる。R2 、R5 、R9 は水素原子又
は低級アルキル基を示し、低級アルキル基としては直鎖
または分枝した炭素原子数1〜4個のアルキル基、例え
ばメチル基、エチル基、プロピル基、イソプロピル基、
ブチル基、ターシャリーブチル基等を挙げることができ
る。Xは水酸基、保護基を有する水酸基、ハロゲン原
子、-OCNHCCl3 、又は下記式で示される基:
[0011] In the above general formula, R 1 , R 4 , R 8
Represents an amino group or a protected amino group. Examples of the protected amino group include an amino group protected by a protecting group known to those skilled in the art as a protecting group for an amino group such as an acetyl group, a phthaloyl group and a 1,2-cyclohexanedicarboxylimide group. R 2 , R 5 , and R 9 represent a hydrogen atom or a lower alkyl group, and the lower alkyl group is a linear or branched alkyl group having 1 to 4 carbon atoms, for example, a methyl group, an ethyl group, a propyl group, Isopropyl group,
Examples thereof include a butyl group and a tertiary butyl group. X is a hydroxyl group, a hydroxyl group having a protective group, a halogen atom, -OCNHCCl 3 , or a group represented by the following formula:

【0012】[0012]

【化10】 [Chemical 10]

【0013】(式中、R3 は水素原子又は水酸基の保護
基である)を示す。Xに含まれる水酸基の保護基又はR
3 で示される水酸基の保護基は、アセチル基、ベンジル
基、ベンゾイル基等の水酸基の保護基として当業者に周
知の保護基ならばいかなるものでもよい。ハロゲン原子
としては、好ましくは塩素原子又はフッ素原子である。
Acはアセチル基を、Piv はピバロイル基を示す。R6
びR11は独立に水酸基の保護基を示し、水酸基の保護基
としてはアセチル基、ベンジル基、ベンゾイル基等の水
酸基の保護基として当業者に周知の保護基ならばいかな
るものも用いることができる。R7 はアミノ基、保護さ
れたアミノ基、またはアジド基を示し、保護されたアミ
ノ基としては、アセチル基、フタロイル基等のアミノ基
の保護基として当業者に周知の保護基で保護されたアミ
ノ基を挙げることができる。R10は水素原子または例え
ばアセチル基等の水酸基の保護基を示す。
(In the formula, R 3 is a hydrogen atom or a hydroxyl-protecting group). Protecting group for hydroxyl group contained in X or R
The hydroxyl-protecting group represented by 3 may be any protecting group known to those skilled in the art as a hydroxyl-protecting group such as an acetyl group, a benzyl group and a benzoyl group. The halogen atom is preferably a chlorine atom or a fluorine atom.
Ac represents an acetyl group and Piv represents a pivaloyl group. R 6 and R 11 independently represent a hydroxyl-protecting group, and as the hydroxyl-protecting group, any protecting group known to those skilled in the art as a hydroxyl-protecting group such as acetyl group, benzyl group and benzoyl group may be used. You can R 7 represents an amino group, a protected amino group, or an azido group, and the protected amino group is protected with a protecting group known to those skilled in the art as a protecting group for amino groups such as acetyl group and phthaloyl group. An amino group may be mentioned. R 10 represents a hydrogen atom or a protective group for a hydroxyl group such as an acetyl group.

【0014】上記の本発明の製造中間体のうち、好まし
い化合物を用いて本発明のガングリオシド化合物デ−N-
アセチル−GM2 を製造する方法の一例を、以下の合成
スキームに示す。スキーム中、Meはメチル基、Acはアセ
チル基、Phthはフタロイル基、Bnはベンジル基、Piv は
ピバロイル基、Etはエチル基、及びBzはベンゾイル基を
示す。また、化合物は特開平3-279395号公報に、化合
はジャーナル・オブ・アメリカン・ケミカル・ソサ
イエティ(J. Am. Chem. Soc., 111(22), 8508-8510, 1
989)) 及びカルボハイドレート・リサーチ(Carbohydr.
Res., 203, 205-217, 1990) に、化合物10はシンレット
(Synlett, 445-448, 1990)に、及び化合物22はカルボハ
イドレートリサーチ(Carbohydr. Res., 158, 113-123,
1986) にそれぞれ記載さている方法により合成すること
ができる。
Among the above-mentioned production intermediates of the present invention, preferred compounds are used to produce the ganglioside compound de-N- of the present invention.
An example of the method for producing acetyl-GM 2 is shown in the following synthetic scheme. In the scheme, Me is a methyl group, Ac is an acetyl group, Phth is a phthaloyl group, Bn is a benzyl group, Piv is a pivaloyl group, Et is an ethyl group, and Bz is a benzoyl group. Compound 1 is described in JP-A-3-279395, and compound 4 is disclosed in Journal of American Chemical Society (J. Am. Chem. Soc., 111 (22), 8508-8510, 1
989)) and Carbohydrate Research (Carbohydr.
Res., 203, 205-217, 1990), compound 10 is a synet
(Synlett, 445-448, 1990), and Compound 22 is Carbohydrate Research (Carbohydr. Res., 158, 113-123,
1986).

【0015】[0015]

【化11】 [Chemical 11]

【0016】[0016]

【化12】 [Chemical 12]

【0017】[0017]

【化13】 [Chemical 13]

【0018】[0018]

【化14】 [Chemical 14]

【0019】上記のスキームに示された反応の反応条件
としては、以下の表1の条件を例示することができる。
表中、DMAPはジメチルアミノピリジン、TMSOTfはトリメ
チルシリルトリフルオロメタンスルホネート、DMTST は
ジメチル(メチルチオ)スルホニウムトリフルオロメタ
ンスルホネート、NIS はN-ヨードサクシンイミド、THF
はテトラヒドロフラン、DMF はN,N-ジメチルホルムアミ
ド、DBU は1,8-ジアザビシクロ[5.4.0] ウンデク-7−エ
ンを示す。
As the reaction conditions of the reaction shown in the above scheme, the conditions shown in Table 1 below can be exemplified.
In the table, DMAP is dimethylaminopyridine, TMSOTf is trimethylsilyltrifluoromethanesulfonate, DMTST is dimethyl (methylthio) sulfonium trifluoromethanesulfonate, NIS is N-iodosuccinimide, THF.
Is tetrahydrofuran, DMF is N, N-dimethylformamide, and DBU is 1,8-diazabicyclo [5.4.0] undec-7-ene.

【0020】[0020]

【表1】 反 応 条 件 ──────────────────────────────────── 化合物No. 反応試薬あるいは触媒 溶 媒 温 度 時 間 ──────────────────────────────────── 既知物質 文献参照 ──────────────────────────────────── 試 薬 触 媒 A Et3Nなどの MeOH, EtOH, 0℃〜50℃ 1〜10日 のN-フタ 3級アミン類 PrOH, H2O 24℃ 5日 ロイル化 B 3級アミン類 試薬A:無水フタル酸 試薬B:オルトメオキシカルボニル C Na2CO3 ベンゾイルクロライド NaHCO3 試薬C:N-カルボエトキシフタル酸 KHCO3 イミド K2CO3 ──────────────────────────────────── 試 薬 触 媒 Ac2O ピリジン等の ピリジン、 0℃〜50℃ 1〜48時間 (上記反応 3級アミン類 THF, CH2Cl2, 24℃ 20時間 中間体の (CH2Cl)2 アセチル DMAP 化) AcCl 3級アミン類 ──────────────────────────────────── CH2N2 MeOH, EtOH 0℃〜30℃ 0.5〜2時間 CH3I NaOH 24℃ MeOH 酸触媒 ──────────────────────────────────── 既知物質 文献参照 ──────────────────────────────────── 触 媒 EtCN,MeCN,PhCN -90℃〜0 ℃ 1〜24時間 AgOTf と PhseCl PrCH, CH2Cl2, -50℃ 8時間 , 〃 と TMSOTf (ClCH2)2, PhCH3, DMTST, NISとTfOH THF, Et2O, C6H6, MeOTf, MeSOTfと CCl4, CHCl3, CuBr2 とAgOTf と MeNO2 nBu4NBr ──────────────────────────────────── のアセチル化 のアセチル化 のアセチ 1〜48時間 と同じ と同じ ル化と同じ 17時間 ──────────────────────────────────── 10 既知物質 文献参照 ──────────────────────────────────── 11, 12 と同じ -90℃〜 0℃ 2〜48時間 と同じ -78℃20℃ 19時間 ──────────────────────────────────── 反応試薬及び触媒 AcSH 0℃〜50℃ 1〜10日 AcSH CH2Cl2, CHCl3, 243日 H2と Pd-C, (ClCH2)2,CHCl3, 13 H2と Pd(OH)2-C THF,Et2O,PhCH3, H2と Pt2O C6H6,AcOEt, CCl4 H2O とPh3P H2S 反応試薬がAcSH以外の場合は還元後にN-アセチル化 ──────────────────────────────────── 13の 反応試薬 触 媒 MeOH,EtOH,PrOH 20℃〜40℃ 5〜80時間 脱ベン H2 Pd(OH2)-C AcOEt 24℃ 48時間 ジル化 Pd-C D Pd-C D:シクロヘキサン E Pd-C E:1,3-シクロヘキサジエン ──────────────────────────────────── 14, 15, のアセチル のアセチル のアセチル 1〜5 日 16, 17 化と同じ 化と同じ 化と同じ 3日 (上記化合物の アセチル化) ──────────────────────────────────── 18, 19 反応試薬 DMF 40℃〜80℃ 5 〜90分 H2NNH2・AcOH, 65℃ 30分 ピペリジン酢酸 ──────────────────────────────────── 20, 21 反応試薬 触 媒 (ClCH2) 2 -20℃〜40℃ 1〜24時間 Cl3CCN DBU CH2Cl2,CHCl3, 0℃ 3時間 NaH,LiH, CCl4, THF, K2CO3 PhCH3, C6H6 ──────────────────────────────────── 22 既知物質 文献参照 ──────────────────────────────────── 触 媒 CHCl3, CH2Cl2, -80℃〜40℃ 1〜24時間 23, 24 BF3・OEt2 , TMSOTf (ClCH2)2, PhCH3, -18℃〜 0℃ 時間 PPTS, CCl3CHO C6H6, THF, Et2O, CCl4 ──────────────────────────────────── 反応試薬 ピリジン、 50℃〜130 ℃ 0.5〜6時間 25, 26 LiI, NaI, KI コリジン、 110℃ 2時間 ピコリン ──────────────────────────────────── 反応試薬 1級アルキルアミン アルコール類 A法: MeNH 2 A法:MeOH A法:0℃〜50℃ 5〜100 時間 24℃ 50時間 27 B法: MeNHNH2 B法:EtOH B法:24 ℃〜90℃ 5〜100 時間 7548時間 PhNHNH2 と3級アミン 類 ──────────────────────────────────── (注)表中、下線を付した試薬、触媒、溶媒、温度、及び反応時間は好ましい反 応条件を示す。[Table 1] Reaction conditions ──────────────────────────────────── Compound No. Reaction reagent or Catalyst Solvent temperature Time ───────────────────────────────────── 1 References of known substances ── ────────────────────────────────── Reagent Catalyst A Et 3 N, such as MeOH , EtOH, 0 ℃ -50 ° C 1-10 days 1- N-phthal tertiary amines PrOH, H 2 O 24 ° C 5 days Roylation B tertiary amines Reagent A: phthalic anhydride Reagent B: orthomeoxycarbonyl C Na 2 CO 3 Benzoyl chloride NaHCO 3 reagent C: N-carboethoxyphthalic acid KHCO 3 imide K 2 CO 3 ─────────────────────────────── ────── Reagent Catalyst 2 Ac 2 O Pyridine such as pyridine , 0 ℃ to 50 ℃ 1 ~ 48 hours (the above reaction tertiary amines THF, CH 2 Cl 2, 24 ° C 20 hours intermediate (CH 2 Cl) 2 acetyl DMAP) AcCl tertiary amines ──────────── ───────────────────────── CH 2 N 2 MeOH , EtOH 0 ° C to 30 ° C 0.5 to 2 hours 3 CH 3 I NaOH 24 ° C MeOH Acid Catalyst ──────────────────────────────────── 4 Known substances References ──────── ──────────────────────────── Catalyst EtCN , MeCN, PhCN -90 ℃ to 0 ℃ 1 to 24 hours AgOTf and PhseCl PrCH, CH 2 Cl 2 , -50 ℃ 8 hours 5 , 6 , 〃 and TMSOTf (ClCH 2 ) 2 , PhCH 3 , 7 DMTST, NIS and TfOH THF, Et 2 O, C 6 H 6 , MeOTf, MeSOTf and CCl 4 , CHCl 3 , CuBr 2 , AgOTf and MeNO 2 nBu 4 NBr ──────────────────────────────────── 8 , 9, 2 sweat Le of acetyl 1 to 48 hours acetylation 2 of 2 and the same as the same le of the same 17 hours ─────────────────────────── ───────── 10 References to known substances ───────────────────────────────────── 11 , 12 5 , 6 , 7 Same as 7 , 5 , 6 , 7 -90 ℃ to 0 ℃ Same as 2 to 48 hours -78 ℃ to 20 ℃ 19 hours ──────────────── ───────────────────── Reaction reagents and catalysts AcSH 0 ° C to 50 ° C 1 to 10 days AcSH CH 2 Cl 2 , CHCl 3 , 24 ° C 3 days H 2 And Pd-C, (ClCH 2 ) 2 , CHCl 3 , 13 H 2 and Pd (OH) 2 -C THF, Et 2 O, PhCH 3 , H 2 and Pt 2 OC 6 H 6 ,, AcOEt, CCl 4 H 2 O- and Ph 3 PH 2 S reaction reagents other than AcSH are N-acetylated after reduction ────────────────────────────── ──────── 13 Reaction reagent Catalyst M eOH , EtOH, PrOH 20 ℃ ~ 40 ℃ 5 ~ 80 hours Debenben H 2 Pd (OH 2 ) -C AcOEt 24 ℃ 48 hours Zylation Pd-C D Pd-C D: Cyclohexane E Pd-C E: 1, 3-cyclohexadiene ──────────────────────────────────── 14 , 15 , 2 acetyl 2 acetyl Acetyl of 2 ~ 1 to 5 days 16 and 17 Same as same as same as same as 3 days (acetylation of the above compound) ─────────────────────── ────────────── 18, 19 reagent DMF 40 ℃ ~80 ℃ 5 ~90 min H 2 NNH 2 · AcOH, 65 ℃ 30 minutes piperidine acetate ──────── ──────────────────────────── 20 , 21 Reaction reagent Catalyst (ClCH 2 ) 2 -20 ℃ to 40 ℃ 1 to 24 hours Cl 3 CCN DBU CH 2 Cl 2 , CHCl 3 , 0 ℃ 3 hours NaH, LiH, CCl 4 , THF, K 2 CO 3 PhCH 3 , C 6 H 6 ─────────────── ─── ────────────────── 22 known substance literature reference ─────────────────────────── ───────── Catalyst CHCl 3 , CH 2 Cl 2 , -80 ℃ to 40 ℃ 1 to 24 hours 23 , 24 BF 3 OEt 2 , TMSOTf (ClCH 2 ) 2 , PhCH 3 , -18 ℃ ~ 0 ℃ 3 hours PPTS, CCl 3 CHO C 6 H 6 , THF, Et 2 O, CCl 4 ──────────────────────────── ────────── Reaction reagent pyridine , 50 ℃ ~ 130 ℃ 0.5 ~ 6 hours 25 , 26 LiI , NaI, KI Collidine, 110 ℃ 2 hours picoline ───────────── ──────────────────────── Reaction reagent Primary alkylamine Alcohol A method: MeNH 2 A method: MeOH A method: 0 ℃ to 50 ℃ 5 100 hours 24 ° C. 50 h 27 B method: MeNHNH 2 B method: EtOH B method: 24 ° C. to 90 ° C. 5 to 100 hours 75 ° C. 48 hours PhNHNH 2 and tertiary amines ───────── ────────────────────────── (Note) In the table, the underlined reagents, catalysts, solvents, temperature, and reaction time are Indicates the response condition.

【0021】[0021]

【発明の効果】本発明により提供されるガングリオシド
化合物デ−N-アセチル−GM2 は、種々の生理作用、例え
ば抗原性を有するので有用である。例えば、本発明の化
合物を用いてモノクローナル抗体を作成し、このモノク
ローナル抗体により癌やメラノーマ等の診断に用いるこ
とができる。また、本発明の製造中間体を利用すること
により本発明のガングリオシド化合物デ−N-アセチル−
GM2 が効率よく製造される。
INDUSTRIAL APPLICABILITY The ganglioside compound de-N-acetyl-GM 2 provided by the present invention is useful because it has various physiological actions such as antigenicity. For example, a monoclonal antibody can be prepared using the compound of the present invention, and the monoclonal antibody can be used for diagnosis of cancer, melanoma and the like. Further, by utilizing the production intermediate of the present invention, the ganglioside compound de-N-acetyl-
GM 2 is manufactured efficiently.

【0022】[0022]

【実施例】以下に本発明を実施例によりさらに具体的に
説明するが、本発明はこれらの実施例に限定されない。
EXAMPLES The present invention will be described in more detail below with reference to examples, but the present invention is not limited to these examples.

【0023】[0023]

【例1】 化合物の合成 化合物(297 mg、1.0 mmol) 、無水フタル酸(1.777
g、12.0 mmol)およびトリエチルアミン(2.17ml、15.4
mmol)をメタノール(10ml)中、室温で5日間攪拌し
た。反応液を減圧乾固し、残渣にピリジン(10ml)、無水
酢酸(10 ml)およびジメチルアミノピリジン(122 mg 、
1.0 mmol)を加え、室温で20時間攪拌した。反応液を減
圧乾固し、残渣をクロロホルムに溶解し、0.1N-HCl、飽
和食塩水で洗浄後、無水硫酸マグネシウムで乾燥し、溶
媒を減圧留去した。残渣をフラッシュクロマトグラフィ
ー(Wako Gel C-300, 9 : 1 CHCl3- メタノール) にて精
製し、化合物(474 mg、79.7%)を得た。
Example 1 Synthesis of Compound 2 Compound 1 (297 mg, 1.0 mmol), phthalic anhydride (1.777)
g, 12.0 mmol) and triethylamine (2.17 ml, 15.4
mmol) in methanol (10 ml) at room temperature for 5 days. The reaction solution was evaporated to dryness under reduced pressure, and pyridine (10 ml), acetic anhydride (10 ml) and dimethylaminopyridine (122 mg,
(1.0 mmol) was added, and the mixture was stirred at room temperature for 20 hours. The reaction solution was evaporated to dryness under reduced pressure, the residue was dissolved in chloroform, washed with 0.1N-HCl and saturated brine, dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by flash chromatography (Wako Gel C-300, 9: 1 CHCl 3 -methanol) to obtain compound 2 (474 mg, 79.7%).

【0024】〔α〕D +73.2°(c 1.0 CHCl3 中);
RF 0.40 4:1のCHCl3-メタノール中1 H-n.m.r. データ:δH (CDCl3) 7.835(m, 2H,芳香族水
素), 7.727(m, 2H, 芳香族水素), 5.609(dt, 1H, J=5.0
及び 10.9 Hz, H-4), 5.478(ddd, 1H, J=3.0, 5.2 及び
8.5 Hz, H-8), 5.195(dd, 1H, J=1.8及び8.4 Hz, H-
7), 4.983(dd, 1H,J=1.8 及び 10.6 Hz, H-6), 4.299(d
d, 1H, J=4.0 及び12.5 Hz, H-9), 4.240(t, 1H, J=10.
6 Hz, H-5), 4.084(dd, 1H, J=5.1及び12.5 Hz, H-9'),
2.963(dd,1H, J=4.9 及び12.7 Hz, H-3eq), 2.238, 2.
163, 2.146, 1.945 及び1.844(5s,15H, 4 OAc及びSMe),
及び 2.003(t, 1H, J=12.1Hz, H-3ax)。
[Α] D + 73.2 ° (in c 1.0 CHCl 3 );
R F 0.40 4: 1 CHCl 3 in 1 Hn.mr data in methanol: δ H (CDCl 3 ) 7.835 (m, 2H, aromatic hydrogen), 7.727 (m, 2H, aromatic hydrogen), 5.609 (dt, 1H, J = 5.0
And 10.9 Hz, H-4), 5.478 (ddd, 1H, J = 3.0, 5.2 and
8.5 Hz, H-8), 5.195 (dd, 1H, J = 1.8 and 8.4 Hz, H-
7), 4.983 (dd, 1H, J = 1.8 and 10.6 Hz, H-6), 4.299 (d
d, 1H, J = 4.0 and 12.5 Hz, H-9), 4.240 (t, 1H, J = 10.
6 Hz, H-5), 4.084 (dd, 1H, J = 5.1 and 12.5 Hz, H-9 '),
2.963 (dd, 1H, J = 4.9 and 12.7 Hz, H-3eq), 2.238, 2.
163, 2.146, 1.945 and 1.844 (5s, 15H, 4 OAc and SMe),
And 2.003 (t, 1H, J = 12.1Hz, H-3ax).

【0025】[0025]

【例2】 化合物の合成 化合物(41.9mg、70.4μmol)をメタノール (3 ml)に
溶解し、ジアゾメタンのエーテル溶液を室温で、原料
がTLC上で消失するまで加えた。反応液を減圧乾固
し、残渣をフラッシュクロマトグラフィ(C-300、 4 g、
93 : 7 CHCl3-THF) にて精製し、化合物( 38.9 mg、
90.7 % )を得た。1 H-n. m. r. データー:δH(CDCl3) 7.825(m, 2H, 芳香
族水素), 7.731(m, 2H,芳香族水素), 5.501(dt, 1H, J=
5.1 及び 10.6 Hz H-4), 5.454(ddd, 1H, H=2.6, 4.8
及び 9.1 Hz, H-8), 5.172(dd, 1H, J=2.2 及び 8.8
Hz, H-7), 4.873(dd, 1H, J=2.2 及び 10.6 Hz, H-6),
4.239(dd, 1H, J=2.6 及び 12.5 Hz, H-9), 4.218(t,
1H, H=10.6 Hz, H-5), 3.889(s, 3H, OMe), 2.905(dd,
1H, J=5.1及び 12.8 Hz, H-3eq), 2.195, 2.169, 2.15
1, 1.926 及び 1.839(5s, 15H,4.0Ac 及び SMe), 及び
1.988(dd, 1H, H=11.5及び 12.6 Hz, H-3ax). 〔α〕D +75.2° Rf 0.49 9 : 1 CHCl3-THF 中 元素分析 C27H31NO13S 計算値: C, 53.20 ; H,
5.13 ; N, 2.30 実測値: C, 53.67 ; H, 5.16 ; N, 2.12
Example 2 Synthesis of Compound 3 Compound 2 (41.9 mg, 70.4 μmol) was dissolved in methanol (3 ml), and an ether solution of diazomethane was added at room temperature to the starting material 2.
Was added until disappeared on TLC. The reaction solution was evaporated to dryness under reduced pressure, and the residue was subjected to flash chromatography (C-300, 4 g,
93: 7 CHCl 3 -THF) and the compound 3 (38.9 mg,
90.7%). 1 Hn. Mr Data: δH (CDCl 3 ) 7.825 (m, 2H, aromatic hydrogen), 7.731 (m, 2H, aromatic hydrogen), 5.501 (dt, 1H, J =
5.1 and 10.6 Hz H-4), 5.454 (ddd, 1H, H = 2.6, 4.8
And 9.1 Hz, H-8), 5.172 (dd, 1H, J = 2.2 and 8.8
Hz, H-7), 4.873 (dd, 1H, J = 2.2 and 10.6 Hz, H-6),
4.239 (dd, 1H, J = 2.6 and 12.5 Hz, H-9), 4.218 (t,
1H, H = 10.6 Hz, H-5), 3.889 (s, 3H, OMe), 2.905 (dd,
1H, J = 5.1 and 12.8 Hz, H-3eq), 2.195, 2.169, 2.15
1, 1.926 and 1.839 (5s, 15H, 4.0Ac and SMe), and
1.988 (dd, 1H, H = 11.5 and 12.6 Hz, H-3ax). [Α] D + 75.2 ° Rf 0.49 9: 1 CHCl 3 -THF Elemental analysis C 27 H 31 NO 13 S Calculated value: C, 53.20; H,
5.13; N, 2.30 Found: C, 53.67; H, 5.16; N, 2.12

【0026】[0026]

【例3】 化合物及びの合成 化合物(30.7mg、50.4μmol)と化合物(87.5mg、10
9.5 μmol)とをMs 4A(0.10 g)存在下、EtCN(1.4ml)
中、室温で3時間攪拌した。反応混合物を−50℃に冷却
後、これに AgOTf (29.9mg、115.2 μmol)のEtCN(0.4m
l)溶液を加え、更に PhSeCl(21.4mg、109.5 μmol)のE
tCN(0.4 ml)溶液を加え、同温度で8時間攪拌した。
反応液をクロロホルム(100ml)で希釈後、セライト濾過
し、濾液を飽和重曹水(50ml)で洗浄した。洗液をクロ
ロホルム(50ml )で再抽出し、クロロホルム層を合わ
せ、飽和食塩水(100 ml)で洗浄した。溶媒を無水MgSO
4 で乾燥後、減圧乾固した。残渣をセファデックスLH-2
0 (130 ml 、メタノール)でゲル濾過、次いでHPLC(GL
サイエンス社、Inert sil PREP-SIL, 20 x 250mm、CHCl
3- THF 93 : 7、 16ml/min 、UV 260 nm)にて精製し、
化合物(34.1mg、47.1%) 化合物(5.4 mg、7.5%)
および化合物(11.3mg、39.9%)を得た。 〔α〕D +15.4°(c 1.0, CHCl3) 〔α〕D −3.7 °(c 1.0, CHCl3) Rf 0.23 19 : 1 CHCl3 −THF 中 Rf 0.34 19 : 1 CHCl3 −THF 中 元素分析 C78H87NO25 元素分析 C78H87NO25 計算値:C,65.13; H,6.10; N,0.97 計算値:C,65.13; H,6.10; N,0.97 実測値:C,65.00; H,6.12; N,0.91 実測値:C,65.00; H,6.21; N,0.96 〔α〕D +80.4°(c 1.0, CHCl3) Rf 0.31 19 : 1 CHCl3 −THF 中 元素分析 C26H27NO13 計算値:C,55.62; H,4.85; N,2.49 実測値:C,5
6.04; H,4.94; N,2.55 化合物 5 1 H-n. m. r. データー:δH(CDCl3) 7.821(m, 2H, 芳香
族水素), 7.730(m, 2H,芳香族水素), 5.495(m, 2H, H=4
c 及び H-8c), 5.161(dd, 1H, J=2.6 及び 8.6Hz, H-7
c), 5.124(dd, 1H, J=7.7 及び 9.2 Hz, H-2a), 5.026
(dd, 1H, J=2.6及び 10.6 Hz, H-6c), 4.575(d, 1H, J=
7.7 Hz, H-1b), 4.448(d, 1H, J=8.1 Hz, H-1a), 4.188
(dd, 1H, J=3.7 及び 12.5 Hz, H-9c), 4.183(t, 1H,
J=10.6 Hz, H-5c), 4.143(dd, 1H, J=3.3 及び 9.5 H
z, H-3b), 4.082(t, 1H, J=8.8 Hz, H-4a), 3.937(dd,
1H, J=5.5 及び 12.5 Hz, H-9'c), 3.847(s, 3H, OMe),
3.829(br.s, 1H, H-4b), 3.632(t, 1H, J=8.8 Hz, H-3
a), 3.359(dd, 1H, J=7.7及び 9.2 Hz, H-2b), 2.721
(dd, 1H, J=5.1 及び 12.8 Hz, H-3ceq), 2.099,1.92
9, 1.900 及び 1.879(4s. 12H, 4OAc), 1.987(t, 1H,
J=12.5 Hz, H-3cax), 及び 1.130(s, 9H, (CH3)3C). 化合物 6 1 H-n. m. r. データー:δH(CDCl3) 7.827(m, 2H, 芳香
族水素), 7.727(m, 2H,芳香族水素), 5.970(dt, 1H, J=
5.1 及び 11.4 Hz, H-4c), 5.446(dd, 1H, J=2.6 及
び 10.6 Hz, H-6c), 5.280(td, 1H, J=2.9 及び 8.4 H
z, H-8c), 5.227(t, 1H, J=2.6 Hz, H-7c), 5.109(dd,
1H, J=8.1 及び 9.2 Hz, H-2a), 4.888(dd, 1H, J=2.6
及び 12.5 Hz, H-9c), 4.472(d, 1H, J=7.7 Hz, H-1b),
4.427(d,1H, J=8.1 Hz, H-1a), 4.233(t, 1H, J=10.6
Hz, H-5c), 4.050(m, 2H, H-4a 及び H-9'c), 3.618(t,
1H, J=8.8 Hz, H-3a), 3.484(s, 3H, OMe), 3.364(dd
d, 1H, J=2.2, 4.0 及び 9.9 Hz, H-5a), 2.794(dd, 1
H, J=5.1 及び 13.2 Hz, H-3ceq), 2.093, 1.892, 1.86
6, 及び 1.836(4s, 12H, 4OAc), 1.899(t, 1H, J=12.5H
z, H-3cax), 及び 1.129(s, 9H, (CH3)3C). 化合物 7 1 H-n. m. r. データー:δH(CDCl3) 7.855(d, 1H, J=5.
5 Hz, 芳香族水素), 7.845(d, 1H, J=5.5 Hz, 芳香族水
素), 7.751(d, 1H, J=5.5 Hz, 芳香族水素), 7.745(d,
1H, J=5.5 Hz, 芳香族水素), 6.139(dd, 1H, J=2.6 及
び 9.2 Hz, H-4),6.003(d, 1H, J=2.6 Hz, H-3), 5.424
(dt, 1H, J=2.6 及び 6.2 Hz, H-8), 5.252(dd, 1H, J=
2.2 及び 11.4 Hz, H-6), 5.252(dd, 1H, J=2.0 及び
7.0 Hz, H-7), 4.541(dd, 1H, J=9.2 及び 11.4 Hz, H
-5), 4.500(dd, 1H, J=2.9 及び 12.5 Hz, H-9), 4.116
(dd, 1H, J=6.2 及び 12.5 Hz, H-9'), 3.830(s, 3H, O
Me), 2.096, 2.046, 1.964 及び 1.930(4s, 12H, 4OA
c).
Example 3 Synthesis of Compounds 5 , 6 and 7 Compound 3 (30.7 mg, 50.4 μmol) and Compound 4 (87.5 mg, 10
9.5 μmol) and EtCN (1.4 ml) in the presence of Ms 4A (0.10 g).
The mixture was stirred at room temperature for 3 hours. After cooling the reaction mixture to −50 ° C., it was mixed with AgOTf (29.9 mg, 115.2 μmol) EtCN (0.4 m
l) solution was added, and PhSeCl (21.4 mg, 109.5 μmol) E was added.
A tCN (0.4 ml) solution was added, and the mixture was stirred at the same temperature for 8 hours.
The reaction mixture was diluted with chloroform (100 ml), filtered through Celite, and the filtrate was washed with saturated aqueous sodium hydrogen carbonate (50 ml). The washings were re-extracted with chloroform (50 ml), the chloroform layers were combined and washed with saturated saline (100 ml). Solvent is anhydrous MgSO
After drying at 4, it was dried under reduced pressure. Sephadex LH-2 residue
Gel filtration with 0 (130 ml, methanol) followed by HPLC (GL
Science, Inert sil PREP-SIL, 20 x 250mm, CHCl
3 -THF 93: 7, 16 ml / min, UV 260 nm),
Compound 5 (34.1mg, 47.1%) Compound 6 (5.4mg, 7.5%)
And compound 7 (11.3 mg, 39.9%) were obtained. 5 [α] D + 15.4 ° (c 1.0, CHCl 3 ) 6 [α] D −3.7 ° (c 1.0, CHCl 3 ) Rf 0.23 19: 1 CHCl 3 − THF in Rf 0.34 19: 1 CHCl 3 − THF Elemental analysis C 78 H 87 NO 25 Elemental analysis C 78 H 87 NO 25 Calculated value: C, 65.13; H, 6.10; N, 0.97 Calculated value: C, 65.13; H, 6.10; N, 0.97 Measured value: C, 65.00; H, 6.12; N, 0.91 Actual value: C, 65.00; H, 6.21; N, 0.96 7 [α] D + 80.4 ° (c 1.0, CHCl 3 ) Rf 0.31 19: 1 CHCl 3 −THF Medium element Analysis C 26 H 27 NO 13 Calculated: C, 55.62; H, 4.85; N, 2.49 Measured: C, 5
6.04; H, 4.94; N, 2.55 Compound 5 1 Hn. Mr Data: δH (CDCl 3 ) 7.821 (m, 2H, aromatic hydrogen), 7.730 (m, 2H, aromatic hydrogen), 5.495 (m, 2H, H = 4
c and H-8c), 5.161 (dd, 1H, J = 2.6 and 8.6Hz, H-7
c), 5.124 (dd, 1H, J = 7.7 and 9.2 Hz, H-2a), 5.026
(dd, 1H, J = 2.6 and 10.6 Hz, H-6c), 4.575 (d, 1H, J =
7.7 Hz, H-1b), 4.448 (d, 1H, J = 8.1 Hz, H-1a), 4.188
(dd, 1H, J = 3.7 and 12.5 Hz, H-9c), 4.183 (t, 1H,
J = 10.6 Hz, H-5c), 4.143 (dd, 1H, J = 3.3 and 9.5 H
z, H-3b), 4.082 (t, 1H, J = 8.8 Hz, H-4a), 3.937 (dd,
1H, J = 5.5 and 12.5 Hz, H-9'c), 3.847 (s, 3H, OMe),
3.829 (br.s, 1H, H-4b), 3.632 (t, 1H, J = 8.8 Hz, H-3
a), 3.359 (dd, 1H, J = 7.7 and 9.2 Hz, H-2b), 2.721
(dd, 1H, J = 5.1 and 12.8 Hz, H-3ceq), 2.099,1.92
9, 1.900 and 1.879 (4s. 12H, 4OAc), 1.987 (t, 1H,
J = 12.5 Hz, H-3cax), and 1.130 (s, 9H, (CH 3 ) 3 C). Compound 6 1 Hn. Mr Data: δH (CDCl 3 ) 7.827 (m, 2H, aromatic hydrogen), 7.727 (m, 2H, aromatic hydrogen), 5.970 (dt, 1H, J =
5.1 and 11.4 Hz, H-4c), 5.446 (dd, 1H, J = 2.6 and 10.6 Hz, H-6c), 5.280 (td, 1H, J = 2.9 and 8.4 H
z, H-8c), 5.227 (t, 1H, J = 2.6 Hz, H-7c), 5.109 (dd,
1H, J = 8.1 and 9.2 Hz, H-2a), 4.888 (dd, 1H, J = 2.6
And 12.5 Hz, H-9c), 4.472 (d, 1H, J = 7.7 Hz, H-1b),
4.427 (d, 1H, J = 8.1 Hz, H-1a), 4.233 (t, 1H, J = 10.6
Hz, H-5c), 4.050 (m, 2H, H-4a and H-9'c), 3.618 (t,
1H, J = 8.8 Hz, H-3a), 3.484 (s, 3H, OMe), 3.364 (dd
d, 1H, J = 2.2, 4.0 and 9.9 Hz, H-5a), 2.794 (dd, 1
H, J = 5.1 and 13.2 Hz, H-3ceq), 2.093, 1.892, 1.86
6, and 1.836 (4s, 12H, 4OAc), 1.899 (t, 1H, J = 12.5H
z, H-3cax), and 1.129 (s, 9H, (CH 3 ) 3 C). Compound 7 1 Hn. mr Data: δH (CDCl 3 ) 7.855 (d, 1H, J = 5.
5 Hz, aromatic hydrogen), 7.845 (d, 1H, J = 5.5 Hz, aromatic hydrogen), 7.751 (d, 1H, J = 5.5 Hz, aromatic hydrogen), 7.745 (d,
1H, J = 5.5 Hz, aromatic hydrogen), 6.139 (dd, 1H, J = 2.6 and 9.2 Hz, H-4), 6.003 (d, 1H, J = 2.6 Hz, H-3), 5.424
(dt, 1H, J = 2.6 and 6.2 Hz, H-8), 5.252 (dd, 1H, J =
2.2 and 11.4 Hz, H-6), 5.252 (dd, 1H, J = 2.0 and
7.0 Hz, H-7), 4.541 (dd, 1H, J = 9.2 and 11.4 Hz, H
-5), 4.500 (dd, 1H, J = 2.9 and 12.5 Hz, H-9), 4.116
(dd, 1H, J = 6.2 and 12.5 Hz, H-9 '), 3.830 (s, 3H, O
Me), 2.096, 2.046, 1.964 and 1.930 (4s, 12H, 4OA
c).

【0027】[0027]

【例4】 化合物の合成 化合物(15.2mg、0.01 mmol)およびジメチルアミノピ
リジン(3.0 mg 、0.024mmol)をピリジン(0.2 ml)に溶
解し、これに無水酢酸 (50μl)を加え、室温で17時間
攪拌した。反応液を減圧乾固し、残渣をゲル濾過(セフ
ァデックス LH-20, 17ml, メタノール)、次いでフラッ
シュクロマトグラフィー(C-300, 1.8 g, 24 : 1 CHCl3
-THF) にて精製し、化合物(11.8mg、75.6%)を得た。 〔α〕D +17.0°(c 0.58, CHCl3) Rf 0.40 19 : 1 CHCl3 −THF 中 元素分析 C80H89NO26 計算値:C,64.90; H,6.06;
N,0.95 実測値:C,64.40; H,6.18; N,0.991 H-n. m. r. データー:δH(CDCl3) 5.666(ddd, 1H, J=
2.6, 4.4 及び 9.2 Hz,H-8c), 5.576(dt, 1H, J=5.1
及び 11.4 Hz, H-4c), 5.177(dd, 1H, J= 2.6及び 9.2
Hz, H-7c), 5.116(dd, 1H, J=8.4 及び 9.2 Hz, H-2
a), 5.102(br. d,1H, J=3.3 Hz, H-4b), 4.761(dd, 1
H, J=3.3 及び 11.0 Hz, H-6c), 4.761(d, 1H, J=7.7
Hz, H-1b), 4.618(dd, 1H, J=3.3 及び 9.9 Hz, H-3
b), 4.425(d,1H, J=8.1 Hz, H-1a), 4.182(t, 1H, J=1
0.6 Hz, H-5c), 4.165(dd, 1H, J=2.6及び 12.5 Hz, H-
9c, 4.094(t, 1H, J=9.2 Hz, H-4a), 3.963(dd, 1H, J=
4.8及び 12.8 Hz, H-9'c), 3.928(s, 3H, OMe), 3.795
(dd, 1H, J=1.8 及び 11.0Hz, H-6a), 3.628(t, 1H, J
=9.2 Hz, H-3a), 3.465(dd, 1H, J=7.7 及び 9.5 Hz,
H-2b), 3.400(ddd, 1H, J=1.5, 4.8 及び 9.5 Hz, H-5
a), 2.742(dd, 1H, J=5.1 及び 12.5 Hz, H-3ceq), 2.
093, 2.002, 1.858, 1.828 及び 1.815(5s,15H, 50A
c), 1.790(t, 1H, J=12.1 Hz, H-3cax), 及び 1.132
(s, 9H, (CH3)3C).
Example 4 Synthesis of Compound 8 Compound 5 (15.2 mg, 0.01 mmol) and dimethylaminopyridine (3.0 mg, 0.024 mmol) were dissolved in pyridine (0.2 ml), acetic anhydride (50 μl) was added thereto, and the mixture was stirred at room temperature. It was stirred for 17 hours. The reaction mixture was evaporated to dryness under reduced pressure, and the residue was subjected to gel filtration (Sephadex LH-20, 17 ml, methanol), followed by flash chromatography (C-300, 1.8 g, 24: 1 CHCl 3).
-THF) to obtain Compound 8 (11.8 mg, 75.6%). [Α] D + 17.0 ° (c 0.58, CHCl 3 ) Rf 0.40 19: 1 CHCl 3 -THF Elemental analysis C 80 H 89 NO 26 Calculated value: C, 64.90; H, 6.06;
N, 0.95 Found: C, 64.40; H, 6.18; N, 0.99 1 Hn. Mr Data: δH (CDCl 3 ) 5.666 (ddd, 1H, J =
2.6, 4.4 and 9.2 Hz, H-8c), 5.576 (dt, 1H, J = 5.1
And 11.4 Hz, H-4c), 5.177 (dd, 1H, J = 2.6 and 9.2
Hz, H-7c), 5.116 (dd, 1H, J = 8.4 and 9.2 Hz, H-2
a), 5.102 (br. d, 1H, J = 3.3 Hz, H-4b), 4.761 (dd, 1
H, J = 3.3 and 11.0 Hz, H-6c), 4.761 (d, 1H, J = 7.7
Hz, H-1b), 4.618 (dd, 1H, J = 3.3 and 9.9 Hz, H-3
b), 4.425 (d, 1H, J = 8.1 Hz, H-1a), 4.182 (t, 1H, J = 1
0.6 Hz, H-5c), 4.165 (dd, 1H, J = 2.6 and 12.5 Hz, H-
9c, 4.094 (t, 1H, J = 9.2 Hz, H-4a), 3.963 (dd, 1H, J =
4.8 and 12.8 Hz, H-9'c), 3.928 (s, 3H, OMe), 3.795
(dd, 1H, J = 1.8 and 11.0Hz, H-6a), 3.628 (t, 1H, J
= 9.2 Hz, H-3a), 3.465 (dd, 1H, J = 7.7 and 9.5 Hz,
H-2b), 3.400 (ddd, 1H, J = 1.5, 4.8 and 9.5 Hz, H-5
a), 2.742 (dd, 1H, J = 5.1 and 12.5 Hz, H-3ceq), 2.
093, 2.002, 1.858, 1.828 and 1.815 (5s, 15H, 50A
c), 1.790 (t, 1H, J = 12.1 Hz, H-3cax), and 1.132
(s, 9H, (CH 3 ) 3 C).

【0028】[0028]

【例5】 化合物の合成 化合物(6.9mg )を化合物の合成法と同様に行な
い、化合物(6.7mg 、94.4%)へ変換した。 〔α〕D +6.1 °(c 0.35, CHCl3) Rf 0.47 19 : 1 CHCl3 −THF 中 元素分析 C80H89NO26 計算値:C,64.90; H,6.06;
N,0.95 実測値:C,64.48; H,6.21; N,1.021 H-n. m. r. データー:δH(CDCl3) 7.805(m, 2H, 芳香
族水素), 7.703(m, 2H,芳香族水素), 5.835(dt, 1H, J=
4.8 及び 11.0 Hz, H-4c), 5.585(td, 1H, J=2.2 及
び 9.5 Hz, H-8c), 5.300(dd, 1H, J=2.2 及び 12.5 H
z, H-9c), 5.295(d, 1H, J=3.7 Hz, H-4b), 5.268(t, 1
H, J=2.2 Hz, H-7c), 5.122(dd, 1H, J=8.1及び 9.2 H
z, H-2a), 5.058(dd, 1H, J=2.6 及び 10.6 Hz, H-6c),
4.525(d, 1H, J=7.7 Hz, H-1b), 4.432(d, 1H, J=8.1
Hz, H-1a), 4.271(dd, 1H, J=3.7及び9.9 Hz, H-3b),
4.155 (t, 1H, J=10.6 Hz, H-5c), 3.878(dd, 1H, J=9.
5 及び12.1 Hz, H-9'c), 3.838(dd, 1H, J=4.0 及び 7.
0 Hz, H-5b), 3.750(dd, 1H,J=2.2 及び 11.0 Hz, H-6
a), 3.698(dd, 1H, J=5.1及び 11.0 Hz, H-6'a), 3.653
(dd, 1H, J=7.7 及び 9.9 Hz, H-2b), 3.642(t, 1H, J=
9.0 Hz, H-3a), 3.478(dd, 1H, J=4.0 及び 10.6 Hz,
H-6b), 3.390(ddd, 1H, J=1.8, 4.8 及び 9.5Hz, H-5
a), 3.355(s, 3H, OMe), 3.247(dd, 1H, J=7.0 及び 1
0.5 Hz, H-6'b), 2.806 (dd, 1H, J=5.1 及び 13.6 H
z, H-3ceq), 2.277, 2.105, 1.909, 1.850, 及び1.800
(5s, 15H, 5OAc), 1.930(dd, 1H, J=11.4 及び 13.6 H
z, H-3cax), 及び 1.126(s, 9H, (CH3)3C).
Example 5 Synthesis of Compound 9 Compound 6 (6.9 mg) was converted into compound 9 (6.7 mg, 94.4%) by the same method as for the synthesis of compound 8 . [Α] D + 6.1 ° (c 0.35, CHCl 3 ) Rf 0.47 19: 1 CHCl 3 -THF Elemental analysis C 80 H 89 NO 26 Calculated value: C, 64.90; H, 6.06;
N, 0.95 Found: C, 64.48; H, 6.21; N, 1.02 1 Hn. Mr Data: δH (CDCl 3 ) 7.805 (m, 2H, aromatic hydrogen), 7.703 (m, 2H, aromatic hydrogen), 5.835 (dt, 1H, J =
4.8 and 11.0 Hz, H-4c), 5.585 (td, 1H, J = 2.2 and 9.5 Hz, H-8c), 5.300 (dd, 1H, J = 2.2 and 12.5 H
z, H-9c), 5.295 (d, 1H, J = 3.7 Hz, H-4b), 5.268 (t, 1
H, J = 2.2 Hz, H-7c), 5.122 (dd, 1H, J = 8.1 and 9.2 H
z, H-2a), 5.058 (dd, 1H, J = 2.6 and 10.6 Hz, H-6c),
4.525 (d, 1H, J = 7.7 Hz, H-1b), 4.432 (d, 1H, J = 8.1
Hz, H-1a), 4.271 (dd, 1H, J = 3.7 and 9.9 Hz, H-3b),
4.155 (t, 1H, J = 10.6 Hz, H-5c), 3.878 (dd, 1H, J = 9.
5 and 12.1 Hz, H-9'c), 3.838 (dd, 1H, J = 4.0 and 7.
0 Hz, H-5b), 3.750 (dd, 1H, J = 2.2 and 11.0 Hz, H-6
a), 3.698 (dd, 1H, J = 5.1 and 11.0 Hz, H-6'a), 3.653
(dd, 1H, J = 7.7 and 9.9 Hz, H-2b), 3.642 (t, 1H, J =
9.0 Hz, H-3a), 3.478 (dd, 1H, J = 4.0 and 10.6 Hz,
H-6b), 3.390 (ddd, 1H, J = 1.8, 4.8 and 9.5Hz, H-5
a), 3.355 (s, 3H, OMe), 3.247 (dd, 1H, J = 7.0 and 1
0.5 Hz, H-6'b), 2.806 (dd, 1H, J = 5.1 and 13.6 H
z, H-3ceq), 2.277, 2.105, 1.909, 1.850, and 1.800
(5s, 15H, 5OAc), 1.930 (dd, 1H, J = 11.4 and 13.6 H
z, H-3cax), and 1.126 (s, 9H, (CH 3) 3 C).

【0029】[0029]

【例6】 化合物11及び12の合成 化合物(46.1mg)、32μmol)および化合物10 (142.3
mg、245 μmol)をMS 4A(0.46g)存在下、EtCN(1.5 ml)
中、室温で3時間攪拌した。反応混合物を−78℃に冷却
し、 AgOTf (101.5 mg、391 μmol)のEtCN(0.7 ml)溶
液を加え、次いで PhSeCl(73.0mg、374 μmol)のEtCN
(0.8 ml)溶液を加え、同温度で3時間攪拌し、更に−
20℃で16時間攪拌した。反応液をクロロホルム(60ml )
で希釈し、セライト濾過した。濾液を飽和重曹水(30 m
l)で洗浄し、洗液をクロロホルム(30ml )で抽出後、
クロロホルム層を合わせ、飽和食塩水(70 ml)で洗浄し
た。溶媒を無水硫酸マグネシウムで乾燥後、減圧留去し
た。残渣をゲル濾過(セファデックス LH-20、 260ml 、
メタノール) 精製、次いでフラッシュクロマトグラフィ
ー(Wako Gel C-300、 6g、4:1 トルエン-AcOEt )にて精
製し、化合物11(48.2mg、79.3%)および化合物12(8.5
mg、14.0%)を得た。 化合物 11 化合物 12 〔α〕D +3.5°(c 0.98, CHCl3) 〔α〕D +27.7°(c 0.91, CHCl3) Rf 0.34 3:1 トルエン−AcOEt 中 Rf 0.40 3:1 トルエン−AcOEt 中 元素分析 C105H114N4O29 : 元素分析 C105H114N4O29 : 計算値: C,66.51; H,6.06; N,2.95 計算値: C,66.51; H,6.06; N,2.95 実測値: C,65.89; H,6.10; N,2.95 実測値: C,66.72; H,6.11; N,3.04 化合物 11 1 H-n. m. r. データー:δH(CDCl3) 7.830(m, 2H, 芳香
族水素), 7.731(m, 2H,芳香族水素), 5.430(ddd, 1H, J
=5.1, 10.6 及び 11.7 Hz, H-4c), 5.344(ddd,1H, J=2.
5, 4.0 及び 9.5 Hz, H-8c), 5.121 (dd, 1H, J=1.8
及び 9.3 Hz, H-7c), 5.047 (dd, 1H, J=8.1 及び 9.5
Hz, H-2a), 4.656 (d, 1H, J=8.1 Hz,H-1b), 4.474(d,
1H, J=7.7 Hz, H-1d), 4.429(d, 1H, J=8.1 Hz, H-1
a), 4.174(dd, 1H, J=2.9 及び 12.8 Hz, H-9c), 4.11
5(t, 1H, J=10.3 Hz, H-5c), 3.955(dd, 1H, J=4.0
及び 12.8 Hz, H-9 ′c), 3.894(dd, 1H, J=8.1 及び 1
0.6Hz, H-2b), 3.840(dd, 1H, J=7.7 及び 9.5 Hz, H-
2d), 3.768(d, 1H, J=3.3 Hz, H-4b), 3.739(s, 3H, OM
e), 3.577(t, 1H, J=8.8 Hz, H-3a), 3.369 (dd, 1H, J
=2.6 及び 10.6 Hz, H-3b), 2.580(dd, 1H, J=5.1
及び 13.6 Hz, H-3ceq), 2.086(dd, 1H, J=12.0 及び 1
3.6 Hz, H-3cax), 2.068, 1.912, 1.836 及び1.776(4
s, 12H, 4OAc), 及び 1.195(s, 9H, (CH3)3C). 化合物 12 1 H-n. m. r. データー:δH(CDCl3) 7.811(m, 2H, 芳香
族水素), 7.726(m, 2H,芳香族水素), 5.685(ddd, 1H, J
=2.6, 4.4 及び 9.2 Hz, H-8c), 5.506(ddd, 1H, J=5.
1, 11.7 及び 13.5 Hz, H-4c), 5.194(dd, 1H, J=2.6
及び 9.2 Hz, H-7c), 5.104(dd, 1H, J=7.7 及び 9.5
Hz, H-2a), 4.926(d, 1H, J=3.3 Hz, H-1d), 4.860(dd,
1H, J=2.6 及び 10.6 Hz, H-6c), 4.793(d, 1H, J=7.3
Hz, H-1d), 4.412(d, 1H, J=8.1 Hz, H-1a), 4.224(t,
1H, J=10.6 Hz, H-5c), 4.125(dd, 1H, J=2.6 及び 1
2.8 Hz, H-9c), 4.073(br. s, 1H, H-4d), 3.978(t, 1
H, J=9.9 Hz, H-4a), 3.981(dd, 1H, J=4.8 及び 12.5
Hz, H-9 ′c), 3.737(s, 3H,OMe), 3.681(d, 1H, J=2.
2 Hz, H-4b), 3.554(dd, 1H, J=7.3 及び 10.6 Hz,H-2
d), 2.844(dd, 1H, J=4.8 及び 11.8 Hz, H-3ceq), 2.
114, 1.875, 1.826及び 1.565(4s, 12H, 4OAc), 及び
1.061(s, 9H, (CH3)3C).
Example 6 Synthesis of Compounds 11 and 12 Compound 5 (46.1 mg), 32 μmol) and Compound 10 (142.3
mg, 245 μmol) in the presence of MS 4A (0.46 g), EtCN (1.5 ml)
The mixture was stirred at room temperature for 3 hours. The reaction mixture was cooled to −78 ° C. and a solution of AgOTf (101.5 mg, 391 μmol) in EtCN (0.7 ml) was added, followed by PhSeCl (73.0 mg, 374 μmol) in EtCN.
(0.8 ml) solution was added and stirred at the same temperature for 3 hours.
The mixture was stirred at 20 ° C for 16 hours. Chloroform the reaction mixture (60 ml)
It was diluted with and filtered through Celite. The filtrate was saturated with aqueous sodium hydrogen carbonate (30 m
l), wash the solution with chloroform (30 ml),
The chloroform layers were combined and washed with saturated brine (70 ml). The solvent was dried over anhydrous magnesium sulfate and evaporated under reduced pressure. The residue was subjected to gel filtration (Sephadex LH-20, 260 ml,
(Methanol) purification, followed by flash chromatography (Wako Gel C-300, 6 g, 4: 1 toluene-AcOEt) to give compound 11 (48.2 mg, 79.3%) and compound 12 (8.5
mg, 14.0%) was obtained. Compound 11 Compound 12 (α) D + 3.5 ° (c 0.98, CHCl 3 ) (α) D + 27.7 ° (c 0.91, CHCl 3 ) Rf 0.34 3: 1 in toluene-AcOEt Rf 0.40 3: 1 toluene-AcOEt Elemental analysis C 105 H 114 N 4 O 29 : Elemental analysis C 105 H 114 N 4 O 29 : Calculated value: C, 66.51; H, 6.06; N, 2.95 Calculated value: C, 66.51; H, 6.06; N, 2.95 Found: C, 65.89; H, 6.10; N, 2.95 Found: C, 66.72; H, 6.11; N, 3.04 Compound 11 1 Hn. Mr Data: δH (CDCl 3 ) 7.830 (m, 2H, aromatic Hydrogen), 7.731 (m, 2H, aromatic hydrogen), 5.430 (ddd, 1H, J
= 5.1, 10.6 and 11.7 Hz, H-4c), 5.344 (ddd, 1H, J = 2.
5, 4.0 and 9.5 Hz, H-8c), 5.121 (dd, 1H, J = 1.8
And 9.3 Hz, H-7c), 5.047 (dd, 1H, J = 8.1 and 9.5
Hz, H-2a), 4.656 (d, 1H, J = 8.1 Hz, H-1b), 4.474 (d,
1H, J = 7.7 Hz, H-1d), 4.429 (d, 1H, J = 8.1 Hz, H-1
a), 4.174 (dd, 1H, J = 2.9 and 12.8 Hz, H-9c), 4.11
5 (t, 1H, J = 10.3 Hz, H-5c), 3.955 (dd, 1H, J = 4.0
And 12.8 Hz, H-9'c), 3.894 (dd, 1H, J = 8.1 and 1
0.6Hz, H-2b), 3.840 (dd, 1H, J = 7.7 and 9.5 Hz, H-
2d), 3.768 (d, 1H, J = 3.3 Hz, H-4b), 3.739 (s, 3H, OM
e), 3.577 (t, 1H, J = 8.8 Hz, H-3a), 3.369 (dd, 1H, J
= 2.6 and 10.6 Hz, H-3b), 2.580 (dd, 1H, J = 5.1
And 13.6 Hz, H-3ceq), 2.086 (dd, 1H, J = 12.0 and 1
3.6 Hz, H-3cax), 2.068, 1.912, 1.836 and 1.776 (4
s, 12H, 4OAc), and 1.195 (s, 9H, (CH 3 ) 3 C). Compound 12 1 Hn. mr Data: δH (CDCl 3 ) 7.811 (m, 2H, aromatic hydrogen), 7.726 (m, 2H, aromatic hydrogen), 5.685 (ddd, 1H, J
= 2.6, 4.4 and 9.2 Hz, H-8c), 5.506 (ddd, 1H, J = 5.
1, 11.7 and 13.5 Hz, H-4c), 5.194 (dd, 1H, J = 2.6
And 9.2 Hz, H-7c), 5.104 (dd, 1H, J = 7.7 and 9.5
Hz, H-2a), 4.926 (d, 1H, J = 3.3 Hz, H-1d), 4.860 (dd,
1H, J = 2.6 and 10.6 Hz, H-6c), 4.793 (d, 1H, J = 7.3
Hz, H-1d), 4.412 (d, 1H, J = 8.1 Hz, H-1a), 4.224 (t,
1H, J = 10.6 Hz, H-5c), 4.125 (dd, 1H, J = 2.6 and 1
2.8 Hz, H-9c), 4.073 (br.s, 1H, H-4d), 3.978 (t, 1
H, J = 9.9 Hz, H-4a), 3.981 (dd, 1H, J = 4.8 and 12.5
Hz, H-9′c), 3.737 (s, 3H, OMe), 3.681 (d, 1H, J = 2.
2 Hz, H-4b), 3.554 (dd, 1H, J = 7.3 and 10.6 Hz, H-2
d), 2.844 (dd, 1H, J = 4.8 and 11.8 Hz, H-3ceq), 2.
114, 1.875, 1.826 and 1.565 (4s, 12H, 4OAc), and
1.061 (s, 9H, (CH 3 ) 3 C).

【0030】[0030]

【例7】 化合物13の合成 化合物11(103.6mg 、 54.6μmol)をチオ酢酸(1ml)に
溶解し、室温で3日間攪拌した。反応液をゲル濾過(セ
ファデックス LH-20, 90 ml, メタノール) 精製後、更
にフラッシュクロマトグラフィー( Wako Gel C-300, 1
2 g, 19 : 1 CHCl2-THF)にて精製し、化合物13( 87.9
mg、84.2% )を得た。 〔α〕D +16.2°(c 0.80, CHCl3) Rf 0.36 3:2 トルエン−AcOEt 中 元素分析 C107H118N2O30 計算値: C, 67.21 ; H,
6.22 ; N, 1.47 実測値: C, 66.91 ; H, 6.23 ; N, 1.421 H-n. m. r. データー(この化合物はCDCl3 中、13:7
の割合で回転異性体が存在):δH(CDCl3,24℃) 7.836
(m, 2H, 芳香族水素), 7.741(m, 2H, 芳香族水素), 6.
124(d, 0.65H, J=9.5 Hz, NH), 6.018(d, 0.35H, J=10.
3 Hz, NH), 5.664(dt, 0.65H, J=5.5及び10.8 Hz, H-4
c), 5.647(dt, 0.35H, J=5.5及び 10.8 Hz,H-4c), 5.22
8(m, 1H, H-8c), 3.883(s, 1.05H, 0Me), 3.763(s, 1.9
5H, OMe), 2.427(dd, 0.65H, J=5.3 及び 14.1 Hz, H-3
ceq), 2.266(dd, 0.35H, J=5.5 及び13.6 Hz, H-3ceq),
2.152(dd, 0.65H, J=11.7 及び 13.6 Hz, H-3cax),
2.136(dd, 0.35H, H=11.2 及び 13.7 Hz, H-3cax), 2.
036(1.05H), 2.019(1.95H), 1.914(1.05H), 1.904(1.95
H), 1.885(1.05H), 1.860(1.95H), 1.834(1.05H), 1.82
7(1.95H), 1.805(1.95H) 及び 1.786(1.05H)(10s, 15H,
OAc), 1.194(s, 3.15H, (CH3)3C) 及び 1.187(s, 5.8
5H, (CH3)3C).
Example 7 Synthesis of Compound 13 Compound 11 (103.6 mg, 54.6 μmol) was dissolved in thioacetic acid (1 ml), and the mixture was stirred at room temperature for 3 days. The reaction mixture was purified by gel filtration (Sephadex LH-20, 90 ml, methanol) and then flash chromatography (Wako Gel C-300, 1
2 g, 19: 1 CHCl 2 -THF) to give compound 13 (87.9
mg, 84.2%) was obtained. [Α] D + 16.2 ° (c 0.80, CHCl 3 ) Rf 0.36 3: 2 Toluene-AcOEt in elemental analysis C 107 H 118 N 2 O 30 Calculated value: C, 67.21; H,
6.22; N, 1.47 Found: C, 66.91; H, 6.23; N, 1.42 1 Hn. Mr Data (This compound is 13: 7 in CDCl 3
Exists in the ratio of): δH (CDCl 3 , 24 ℃) 7.836
(m, 2H, aromatic hydrogen), 7.741 (m, 2H, aromatic hydrogen), 6.
124 (d, 0.65H, J = 9.5 Hz, NH), 6.018 (d, 0.35H, J = 10.
3 Hz, NH), 5.664 (dt, 0.65H, J = 5.5 and 10.8 Hz, H-4
c), 5.647 (dt, 0.35H, J = 5.5 and 10.8 Hz, H-4c), 5.22
8 (m, 1H, H-8c), 3.883 (s, 1.05H, 0Me), 3.763 (s, 1.9
5H, OMe), 2.427 (dd, 0.65H, J = 5.3 and 14.1 Hz, H-3
ceq), 2.266 (dd, 0.35H, J = 5.5 and 13.6 Hz, H-3ceq),
2.152 (dd, 0.65H, J = 11.7 and 13.6 Hz, H-3cax),
2.136 (dd, 0.35H, H = 11.2 and 13.7 Hz, H-3cax), 2.
036 (1.05H), 2.019 (1.95H), 1.914 (1.05H), 1.904 (1.95
H), 1.885 (1.05H), 1.860 (1.95H), 1.834 (1.05H), 1.82
7 (1.95H), 1.805 (1.95H) and 1.786 (1.05H) (10s, 15H,
OAc), 1.194 (s, 3.15H , (CH 3) 3 C) and 1.187 (s, 5.8
5H, (CH 3 ) 3 C).

【0031】[0031]

【例8】 化合物141516及び17の合成 化合物13(97.5mg)、51.0μmol)及び20% Pd(OH)2-C(362
mg) をMeOH(10ml)中、水素ガス雰囲気下に室温で48時間
攪拌した。反応液を濾過し、濾液を減圧乾固した。残渣
をピリジン(1ml)に溶解し、ジメチルアミノピリジン
(12.4mg、0.1mmol) および無水酢酸(1ml)を加え、室
温で3日間攪拌した。反応液を減圧乾固し、残渣をゲル
濾過(セファデックス LH-20, 130 ml, MeOH) 精製、次
いで HPLC (GL サイエンス社製、Inert sil PREP-SIL,
20 x 250 mm,トルエン-THF 7:3,16ml/min) 精製、更に
HPLC (GL サイエンス社製 Inert sil PREP-SIL, 20 x 2
50 mm, AcOEt, 16ml/min)による再精製を行ない、化合
14(11.9mg、15.3%)、化合物15(10.1 mg、 13.0%)、 化
合物16(21.0mg、 26.9%)及び化合物17(20.8mg、 26.6%)
を得た。
Example 8 Synthesis of Compounds 14 , 15 , 16 and 17 Compound 13 (97.5 mg), 51.0 μmol) and 20% Pd (OH) 2 -C (362
mg) in MeOH (10 ml) under hydrogen gas atmosphere and stirred at room temperature for 48 hours. The reaction solution was filtered, and the filtrate was dried under reduced pressure. The residue was dissolved in pyridine (1 ml), dimethylaminopyridine (12.4 mg, 0.1 mmol) and acetic anhydride (1 ml) were added, and the mixture was stirred at room temperature for 3 days. The reaction solution was evaporated to dryness under reduced pressure, the residue was purified by gel filtration (Sephadex LH-20, 130 ml, MeOH), and then HPLC (GL Science, Inert sil PREP-SIL,
20 x 250 mm, Toluene-THF 7: 3, 16 ml / min)
HPLC (GL Science Inert sil PREP-SIL, 20 x 2
50 mm, AcOEt, 16 ml / min) for re-purification to obtain compound 14 (11.9 mg, 15.3%), compound 15 (10.1 mg, 13.0%), compound 16 (21.0 mg, 26.9%) and Compound 17 (20.8 mg, 26.6%)
Got

【0032】 14 15 〔α〕D +40.9°(c 0.33, CHCl3) 〔α〕D +17.4°(c 0.56, CHCl3) Rf 0.38 3:2 トルエン−THF 中 Rf 0.42 3:2トルエン−THF 中 Rf 0.38 AcOEt中 Rf 0.42 AcOEt 中 16 17 〔α〕D +17.9°(c 0.66, CHCl3) 〔α〕D − 1.4°(c 1.23, CHCl3) Rf 0.37 3:2 トルエン−THF 中 Rf 0.42 3:2トルエン−THF 中 Rf 0.33 AcOEt中 Rf 0.37 AcOEt 中 化合物 14(α体)1 H-n. m. r. データー:δH(CDCl3) 7.819(m,2H,芳香族
水素), 7.730(m, 2H, 芳香族水素), 6.305(d, 1H, J=3.
7 Hz, H-1a), 6.069(d, 1H, J=7.3 Hz, NH), 5.829((d
d, 1H, J=3.3 及び 11.0 Hz, H-3d), 5.575(dd, 1H, J=
2.9 及び 9.9 Hz,H-8c), 5.498(dt, 1H, J=5.6 及び 1
1.0 Hz, H-4c), 5.480(t, 1H, J=9.7 Hz,H-3a), 5.367
(d, 1H, J=3.3 Hz, H-4d), 5.244(d, 1H, J=2.2 及び
9.5 Hz, H-7c), 5.123(d, 1H, J=8.4 Hz, H-1d), 5.004
(dd, 1H, J=7.3 及び 10.6 Hz, H-2b), 4.987(dd. 1H,
J=3.7及び 10.3 Hz, H-2a), 4.879(dd, 1H, J=2.9及び
11.0Hz, H-6c), 4.630(d, 1H, J=7.7 Hz, H-1b), 4.338
(dd, 1H, J=2.4及び 10.1 Hz, H-3b), 4.284(dd, 1H, J
=2.6 及び 9.2 Hz, H-9c), 4.105(t, 1H, J=10.6 Hz,
H-5c), 3.981(dd, 1H, J=4.2 及び 9.0 Hz, H-9'c),
3.930(s, 3H, OMe), 3.596(br. d, 1H, J=2.2 Hz, H-4
b), 3.432(td, 1H, J=7.7 及び 11.0 Hz, H-2d),2.955
(dd, 1H, J=4.4 及び 12.8 Hz, H-3ceq), 2.258, 2.17
1, 2.164, 2.143,2.109, 2.098, 2.091, 2.072, 2.030,
2.008, 1.994, 1.942 及び 1.834(13s,39H, 13OAc),
1.782(t, J=11.0 Hz, H-3cax), 及び 1.135(s, 9H, (CH
3)3C). 化合物 15(β体)1 H-n. m. r. データー:δH(CDCl3) 7.817(m,2H, 芳香
族水素), 7.731(m, 2H,芳香族水素), 6.072(d, 1H, J=
7.0 Hz, NH), 5.843(dd, 1H, J=3.5 及び 11.2Hz, H-3
d), 5.712(d, 1H, J=8.4 Hz, H-1a), 5.578(ddd, 1H, J
=2.9, 4.0 及び9.9 Hz, H-8c), 5.493(dt, 1H, J=4.8
及び 11.7 Hz, H-4c), 5.363(d, 1H, J=3.3 Hz, H-4d),
5.262(t, 1H, J=9.5 Hz, H-3a), 5.236(dd, 1H, J=2.9
及び 9.5 Hz, H-7c), 5.131(d, 1H, J=8.1 Hz, H-1
d), 5.069(dd, 1H, J=8.3 及び 9.9Hz, H-2a), 4.987(d
d, 1H, J=7.7 及び 9.9 Hz, H-2b), 4.876(dd, 1H, J=
2.9及び 11.0 Hz, H-6c), 4.618(d, 1H, J=7.7 Hz, H-1
b), 4.329(dd, 1H, J=2.6及び 10.3 Hz, H-3b), 4.272
(dd, 1H, J=2.9 及び 12.8 Hz, H-9c), 4.103(t,1H, J
=10.6 Hz, H-5c), 3.973(dd, 1H, J=4.4 及び 12.8 Hz,
H-9 ′c), 3.916(t, 1H, J=9.5 Hz, H-4a), 3.924(s,
3H, OMe), 3.755(ddd, 1H, J=2.2, 5.5, 及び 9.5 Hz,
H-5a), 3.582(br. d, 1H, J=2.2 Hz, H-4b), 3.399(td,
1H, J=8.1及び 11.0 Hz, H-2d), 2.955(dd, 1H, J=5.0
及び 13.0 Hz, H-3ceq), 2.246,2.168, 2.137, 2.11
2, 2.099, 2.089, 2.071, 2.063, 2.027, 1.995, 1.988
1.948, 及び 1.830(13s, 39H, 13OAc), 1.721(t, 1H,
J=12.5 Hz, H-3cax), 及び 1.144(s, 9H, (CH3)3C). 化合物 16(α体)1 H-n. m. r. データー:δH(CDCl3) 6.302(d, 1H, J=3.
7 Hz, H-1a), 6.025(d,0.4H, J=7.3 Hz, NHtrans), 5.9
90(d, 0.6H, J=7.3 Hz, NHcis), 5.840(dd, 0.4H, J=3.
7 及び 11.4 Hz, H-3dtrans), 5.783(dd, 0.6H, J=3.7
及び 11.4 Hz,H-3dcis), 5.537(td, 0.6H, J=3.3 及び
9.5 Hz, H-8ccis), 5.359(br. s, 1H,H-4d), 5.156(d
d, 0.6H, J=2.6 及び 9.9 Hz, H-7ccis), 5.124(dd,
0.4H, J=2.6 及び 9.9 Hz, H-7ctrans), 5.091(d, 1H,
J=8.4 Hz, H-1d), 4.982(dd, 1H,J=3.7 及び 10.3 H
z, H-2a), 4.798(dd, 0.4H, J=2.9 及び 11.0 Hz, H-6
ctrans), 4.793(dd, 0.6H, J=2.9 及び 11.0 Hz, H-6cc
is), 4.605(d, 0.6H, J=8.1Hz, H-1bcis), 4.594(d, 0.
4H, J=7.7 Hz, H-1btrans), 4.320(dd, 0.4H, J=2.4 及
び 10.4 Hz, H-3btrans), 3.892(s, 1.8H, OMecis), 3.
881(s, 1.2H, OMetrans), 3.515(d, 0.4H, J=2.2 Hz, H
-4btrans), 3.566(d, 0.6H, J=2.2 Hz, H-4bcis), 3.45
4(td, 0.6H, J=8.1 及び 10.6 Hz, H-2dcis), 3.401(t
d, 0.4H, J=7.7 及び 11.0 Hz, H-2dtrans), 2.930(dd,
0.6H, J=4.8 及び 13.2 Hz, H-3ceg cis), 2.892(dd,
0.4H, J=5.1 及び 12.8 Hz, H-3ceq cis), 2.818(m,
1.2H, シクロヘキサン環 H-1及び H-2cis), 2.711(q,
0.4H, J=7.0 Hz,シクロヘキサン環H-1 or H-2trans),
2.641(q, 0.4H, J=7.3 Hz, シクロヘキサン環 H-1 or H
-2trans), 2.228, 2.209, 2.162, 2.159, 2.148, 2.14
0, 2.097, 2.086, 2.060, 2.044, 2.030, 2.022, 2.01
5, 2.000, 1.990, 1.969 及び 1.954(17S, 39H, OAc),
及び 1.131(s, 9H, (CH3)3C). 化合物 17(β体)1 H-n. m. r. データー:δH(CDCl3) 6.017(d, 0.4H, J=
7.0 Hz, NHtrans), 5.982(d, 0.6H, J=7.3 Hz, NHtci
s), 5.848(dd, 0.4H, J=3.3 及び 11.7 Hz, H-3dtran
s), 5.794(dd, 0.6H, J=3.3 及び 11.4 Hz, H-3dcis),
5.706(d, 1H, J=8.4 Hz, H-1a), 5.538(td, 0.6H, J=2.
6 及び 10.3 Hz, H-8ccis), 5.477(td. 0.4H,J=2.6 及
び 9.6 Hz, H-8ctrans), 5.425(m, 1H, H-4c), 5.355(b
r. s. 1H, H-4d), 5.249(br. t, 1H, J=9.4 Hz, H-3a),
5.149(dd, 0.6H, J=2.6 及び 10.3 Hz, H-7ccis), 5.
116(dd, 0.4H, J=2.2 及び 10.6 Hz, H-7ctrans), 5.09
4(d, 1H,J=8.4 Hz, H-1d), 5.065(t, 1H, J=8.4 Hz, H-
2a), 4.957(t, 1H, J=8.1 Hz, H-2b), 4.791(m, 1H, H-
6c), 4.595(d, 0.4H, J=7.3 Hz, H-1btrans), 4.584(d,
0.6H, J=7.7 Hz, H-1bcis), 4.037(dd, 0.6H, J=4.0 及
び 12.8 Hz, H-9ccis),3.886(s, 1.8H, OMecis), 3.876
(s, 1.2H, OMetrans), 3.739(m, 1H, H-5a), 3.554(br.
s, 1H, H-4b), 3.423(td, 0.6H, J=8.1 及び 11.0 Hz,
H-2dcis), 3.372(td, 0.4H, J=8.1 及び 10.3 Hz, H-2
dtrans), 2.928(dd, 0.6H, J=5.1 及び 12.5 Hz, H-3ce
q cis), 2.891(dd, 0.4H, J=5.1及び 13.2 Hz, H-3ceq
trans), 2.814(m, 1.2H, シクロヘキサン環 H-1 及び
H-2cis), 2.708(q, 0.4H, J=7.7 Hz,シクロヘキサン環
H-1 or H-2trans), 2.637(q, 0.4H, J=6.8 Hz, シクロ
ヘキサン環 H-1 or H-2trans), 2.214, 2.197, 2.160,
2.145, 2.132, 2.101, 2.084, 2.069, 2.052, 2.044,
2.031, 2.019, 2.005, 1.984, 1.975, 1.966 及び 1.95
2(17S, 39H, OAc), 及び 1.140(s, 9H, (CH3)3C).
14 15 [α] D + 40.9 ° (c 0.33, CHCl 3 ) [α] D + 17.4 ° (c 0.56, CHCl 3 ) Rf 0.38 3: 2 Toluene-Rf 0.42 3: 2 Toluene in THF -THF Rf 0.38 AcOEt Rf 0.42 AcOEt 16 17 (α) D + 17.9 ° (c 0.66, CHCl 3 ) (α) D − 1.4 ° (c 1.23, CHCl 3 ) Rf 0.37 3: 2 Toluene-THF Medium Rf 0.42 3: 2 Toluene-THF Medium Rf 0.33 AcOEt Medium Rf 0.37 AcOEt Medium 14 (α form) 1 Hn. Mr Data: δH (CDCl 3 ) 7.819 (m, 2H, aromatic hydrogen), 7.730 (m, 2H, aromatic hydrogen), 6.305 (d, 1H, J = 3.
7 Hz, H-1a), 6.069 (d, 1H, J = 7.3 Hz, NH), 5.829 ((d
d, 1H, J = 3.3 and 11.0 Hz, H-3d), 5.575 (dd, 1H, J =
2.9 and 9.9 Hz, H-8c), 5.498 (dt, 1H, J = 5.6 and 1
1.0 Hz, H-4c), 5.480 (t, 1H, J = 9.7 Hz, H-3a), 5.367
(d, 1H, J = 3.3 Hz, H-4d), 5.244 (d, 1H, J = 2.2 and
9.5 Hz, H-7c), 5.123 (d, 1H, J = 8.4 Hz, H-1d), 5.004
(dd, 1H, J = 7.3 and 10.6 Hz, H-2b), 4.987 (dd. 1H,
J = 3.7 and 10.3 Hz, H-2a), 4.879 (dd, 1H, J = 2.9 and
11.0Hz, H-6c), 4.630 (d, 1H, J = 7.7 Hz, H-1b), 4.338
(dd, 1H, J = 2.4 and 10.1 Hz, H-3b), 4.284 (dd, 1H, J
= 2.6 and 9.2 Hz, H-9c), 4.105 (t, 1H, J = 10.6 Hz,
H-5c), 3.981 (dd, 1H, J = 4.2 and 9.0 Hz, H-9'c),
3.930 (s, 3H, OMe), 3.596 (br. D, 1H, J = 2.2 Hz, H-4
b), 3.432 (td, 1H, J = 7.7 and 11.0 Hz, H-2d), 2.955
(dd, 1H, J = 4.4 and 12.8 Hz, H-3ceq), 2.258, 2.17
1, 2.164, 2.143, 2.109, 2.098, 2.091, 2.072, 2.030,
2.008, 1.994, 1.942 and 1.834 (13s, 39H, 13OAc),
1.782 (t, J = 11.0 Hz, H-3cax), and 1.135 (s, 9H, (CH
3 ) 3 C). Compound 15 (β-form) 1 Hn. Mr Data: δH (CDCl 3 ) 7.817 (m, 2H, aromatic hydrogen), 7.731 (m, 2H, aromatic hydrogen), 6.072 (d, 1H) , J =
7.0 Hz, NH), 5.843 (dd, 1H, J = 3.5 and 11.2Hz, H-3
d), 5.712 (d, 1H, J = 8.4 Hz, H-1a), 5.578 (ddd, 1H, J
= 2.9, 4.0 and 9.9 Hz, H-8c), 5.493 (dt, 1H, J = 4.8
And 11.7 Hz, H-4c), 5.363 (d, 1H, J = 3.3 Hz, H-4d),
5.262 (t, 1H, J = 9.5 Hz, H-3a), 5.236 (dd, 1H, J = 2.9
And 9.5 Hz, H-7c), 5.131 (d, 1H, J = 8.1 Hz, H-1
d), 5.069 (dd, 1H, J = 8.3 and 9.9Hz, H-2a), 4.987 (d
d, 1H, J = 7.7 and 9.9 Hz, H-2b), 4.876 (dd, 1H, J =
2.9 and 11.0 Hz, H-6c), 4.618 (d, 1H, J = 7.7 Hz, H-1
b), 4.329 (dd, 1H, J = 2.6 and 10.3 Hz, H-3b), 4.272
(dd, 1H, J = 2.9 and 12.8 Hz, H-9c), 4.103 (t, 1H, J
= 10.6 Hz, H-5c), 3.973 (dd, 1H, J = 4.4 and 12.8 Hz,
H-9′c), 3.916 (t, 1H, J = 9.5 Hz, H-4a), 3.924 (s,
3H, OMe), 3.755 (ddd, 1H, J = 2.2, 5.5, and 9.5 Hz,
H-5a), 3.582 (br. D, 1H, J = 2.2 Hz, H-4b), 3.399 (td,
1H, J = 8.1 and 11.0 Hz, H-2d), 2.955 (dd, 1H, J = 5.0
And 13.0 Hz, H-3ceq), 2.246, 2.168, 2.137, 2.11
2, 2.099, 2.089, 2.071, 2.063, 2.027, 1.995, 1.988
1.948, and 1.830 (13s, 39H, 13OAc), 1.721 (t, 1H,
J = 12.5 Hz, H-3cax), and 1.144 (s, 9H, (CH 3 ) 3 C). Compound 16 (α-form) 1 Hn. Mr data: δH (CDCl 3 ) 6.302 (d, 1H, J = 3.
7 Hz, H-1a), 6.025 (d, 0.4H, J = 7.3 Hz, NHtrans), 5.9
90 (d, 0.6H, J = 7.3 Hz, NHcis), 5.840 (dd, 0.4H, J = 3.
7 and 11.4 Hz, H-3dtrans), 5.783 (dd, 0.6H, J = 3.7
And 11.4 Hz, H-3dcis), 5.537 (td, 0.6H, J = 3.3 and
9.5 Hz, H-8ccis), 5.359 (br.s, 1H, H-4d), 5.156 (d
d, 0.6H, J = 2.6 and 9.9 Hz, H-7ccis), 5.124 (dd,
0.4H, J = 2.6 and 9.9 Hz, H-7ctrans), 5.091 (d, 1H,
J = 8.4 Hz, H-1d), 4.982 (dd, 1H, J = 3.7 and 10.3 H
z, H-2a), 4.798 (dd, 0.4H, J = 2.9 and 11.0 Hz, H-6
ctrans), 4.793 (dd, 0.6H, J = 2.9 and 11.0 Hz, H-6cc
is), 4.605 (d, 0.6H, J = 8.1Hz, H-1bcis), 4.594 (d, 0.
4H, J = 7.7 Hz, H-1btrans), 4.320 (dd, 0.4H, J = 2.4 and 10.4 Hz, H-3btrans), 3.892 (s, 1.8H, OMecis), 3.
881 (s, 1.2H, OMetrans), 3.515 (d, 0.4H, J = 2.2 Hz, H
-4btrans), 3.566 (d, 0.6H, J = 2.2 Hz, H-4bcis), 3.45
4 (td, 0.6H, J = 8.1 and 10.6 Hz, H-2dcis), 3.401 (t
d, 0.4H, J = 7.7 and 11.0 Hz, H-2dtrans), 2.930 (dd,
0.6H, J = 4.8 and 13.2 Hz, H-3ceg cis), 2.892 (dd,
0.4H, J = 5.1 and 12.8 Hz, H-3ceq cis), 2.818 (m,
1.2H, cyclohexane ring H-1 and H-2cis), 2.711 (q,
0.4H, J = 7.0 Hz, cyclohexane ring H-1 or H-2trans),
2.641 (q, 0.4H, J = 7.3 Hz, cyclohexane ring H-1 or H
-2trans), 2.228, 2.209, 2.162, 2.159, 2.148, 2.14
0, 2.097, 2.086, 2.060, 2.044, 2.030, 2.022, 2.01
5, 2.000, 1.990, 1.969 and 1.954 (17S, 39H, OAc),
And 1.131 (s, 9H, (CH 3 ) 3 C). Compound 17 (β-form) 1 Hn. Mr Data: δH (CDCl 3 ) 6.017 (d, 0.4H, J =
7.0 Hz, NHtrans), 5.982 (d, 0.6H, J = 7.3 Hz, NHtci
s), 5.848 (dd, 0.4H, J = 3.3 and 11.7 Hz, H-3dtran
s), 5.794 (dd, 0.6H, J = 3.3 and 11.4 Hz, H-3dcis),
5.706 (d, 1H, J = 8.4 Hz, H-1a), 5.538 (td, 0.6H, J = 2.
6 and 10.3 Hz, H-8ccis), 5.477 (td.0.4H, J = 2.6 and 9.6 Hz, H-8ctrans), 5.425 (m, 1H, H-4c), 5.355 (b
rs 1H, H-4d), 5.249 (br. t, 1H, J = 9.4 Hz, H-3a),
5.149 (dd, 0.6H, J = 2.6 and 10.3 Hz, H-7ccis), 5.
116 (dd, 0.4H, J = 2.2 and 10.6 Hz, H-7ctrans), 5.09
4 (d, 1H, J = 8.4 Hz, H-1d), 5.065 (t, 1H, J = 8.4 Hz, H-
2a), 4.957 (t, 1H, J = 8.1 Hz, H-2b), 4.791 (m, 1H, H-
6c), 4.595 (d, 0.4H, J = 7.3 Hz, H-1btrans), 4.584 (d,
0.6H, J = 7.7 Hz, H-1bcis), 4.037 (dd, 0.6H, J = 4.0 and 12.8 Hz, H-9ccis), 3.886 (s, 1.8H, OMecis), 3.876
(s, 1.2H, OMetrans), 3.739 (m, 1H, H-5a), 3.554 (br.
s, 1H, H-4b), 3.423 (td, 0.6H, J = 8.1 and 11.0 Hz,
H-2dcis), 3.372 (td, 0.4H, J = 8.1 and 10.3 Hz, H-2
dtrans), 2.928 (dd, 0.6H, J = 5.1 and 12.5 Hz, H-3ce
q cis), 2.891 (dd, 0.4H, J = 5.1 and 13.2 Hz, H-3ceq
trans), 2.814 (m, 1.2H, cyclohexane ring H-1 and
H-2cis), 2.708 (q, 0.4H, J = 7.7 Hz, cyclohexane ring
H-1 or H-2trans), 2.637 (q, 0.4H, J = 6.8 Hz, cyclohexane ring H-1 or H-2trans), 2.214, 2.197, 2.160,
2.145, 2.132, 2.101, 2.084, 2.069, 2.052, 2.044,
2.031, 2.019, 2.005, 1.984, 1.975, 1.966 and 1.95
2 (17S, 39H, OAc), and 1.140 (s, 9H, (CH 3 ) 3 C).

【0033】[0033]

【例9】 化合物18の合成 化合物14及び15の混合物(16.2mg、 10.6μmol)を無水ジ
メチルホルムアミド(1ml)に溶解し、65℃のオイルバス
上でヒドラジン酢酸(2.0mg、21.7μmol)を加え、同温
度で30分攪拌した。反応液をクロロホルム(20ml)で希釈
し、水 (10 ml)で洗浄した。洗液をクロロホルム(10ml
x 3 )で再抽出後、クロロホルム層を合わせ、飽和食塩
水(50 ml) で洗浄し、無水硫酸マグネシウムで乾燥し
た。溶媒を減圧留去し、残渣をフラッシュクロマトグラ
フィー(C-300, 1.8g, CHCl3-MeOH97 : 3)にて精製し、
化合物18 (12.8mg、 81.3%)を得た。 〔α〕D +32.8°(c 0.76, CHCl3) Rf 0.15 97:3 CHCl3-MeOH 中1 H-n. m. r. データー:δH(CDCl3) 7.819(m, 2H, 芳香
族水素), 7.735(m, 2H,芳香族水素), 6.303(d, 0.7H, J
=7.0 Hz, NHα), 6.173(d, 0.3H, J=7.3 Hz, NHβ), 5.
920(dd, 0.7H, J=3.3 及び 11.0 Hz, H-3dα), 5.845
(dd, 0.3H, J=3.5及び 11.0 Hz, H-3dβ), 5.577(td,1
H, J=3.7 及び 9.5 Hz, H-8c), 5.538(dd, 0.7H, J=9.2
及び 9.9 Hz, H-3aα), 5.491(ddd, 1H, J=4.8, 10.
3 及び 12.1 Hz, H-4c), 5.397(br. d, 0.7H, J=2.6 H
z, H-1aα), 5.370(d, 0.7H, J=2.9 Hz, H-4dα), 5.36
4(d, 0.3H, J=2.6 Hz, H-4dβ), 5.275(t, 0.3H, J=9.5
Hz, H-3aβ), 5.249(dd, 0.7H, J=2.6 及び 9.9 Hz,
H-7cα), 5.241(dd, 0.3H,J=2.9 及び 9.9 Hz, H-7c
β), 5.159(d, 0.7H, J=8.1 Hz, H-1dα), 5.131(d, 0.
3H, J=8.4 Hz, H-1dβ), 5.007(dd, 0.7H, J=8.1及び 1
0.3 Hz, H-2bα), 4.987(dd, 0.3H, J=8.1 及び 10.6
Hz, H-2bβ), 4.880(dd, 1H, J=2.6及び 10.6 Hz, H-6
c), 4.798(dd, 0.7H, J=3.7及び 10.3 Hz, H-2aα), 4.
778(dd, 0.3H,J=8.1及び9.9 Hz, H-2aβ), 4.692(br.
t, 0.3H, J=7.7 Hz, H-1aβ), 4.611(d, 1H, J=7.7 Hz,
H-1b), 4.332(dd, 0.3H, J=2.8 及び 9.9 Hz, H-3b
β), 4.329(dd, 0.7H, J=2.6 及び 10.3 Hz, H-3bα),
4.100(t, 1H, J=10.6 Hz, H-Sc), 3.926(s, 0.9H, OMe
β), 3.923(s, 2.1H, OMeα), 3.852(t, 0.7H, J=9.2
Hz, H-3aα), 3.829(t, 0.3H, J=9.5 Hz, H-3aβ), 3.5
84(d, 0.3H, J=2.2 Hz, H-4bβ), 3.580(d, 0.7H, J=2.
2 Hz, H-4bα), 3.399(td, 0.3H, J=8.1 及び 11.0 H
z, H-2dβ), 3.338(td, 0.7H, J=8.1 及び 10.6 Hz, H
-2dα), 2.975(dd, 1H, J=5.1 及び 12.6 Hz, H-3ce
q), 2.246, 2.171, 2.138, 2.134, 2.109, 2.104, 2.10
1, 2.098, 2.071, 2.067, 2.028, 1.995, 1.991, 1.832
及び 1.828(16s, 36H, OAc), 1.725(t, 1H, J=12.5 H
z, H-3cax), 及び 1.190(s, 9H, (CH3)3C).
Example 9 Synthesis of Compound 18 A mixture of Compounds 14 and 15 (16.2 mg, 10.6 μmol) was dissolved in anhydrous dimethylformamide (1 ml), and hydrazine acetic acid (2.0 mg, 21.7 μmol) was added on an oil bath at 65 ° C. In addition, the mixture was stirred at the same temperature for 30 minutes. The reaction solution was diluted with chloroform (20 ml) and washed with water (10 ml). Chloroform (10 ml
After re-extraction with (x3), the chloroform layers were combined, washed with saturated brine (50 ml), and dried over anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure, the residue was purified by flash chromatography (C-300, 1.8 g, CHCl 3 -MeOH 97: 3),
Compound 18 (12.8 mg, 81.3%) was obtained. [Α] D + 32.8 ° (c 0.76, CHCl 3) Rf 0.15 97: 3 CHCl 3 -MeOH in 1 Hn mr data:. ΔH (CDCl 3) 7.819 (m, 2H, aromatic hydrogens), 7.735 (m , 2H, aromatic hydrogen), 6.303 (d, 0.7H, J
= 7.0 Hz, NHα), 6.173 (d, 0.3H, J = 7.3 Hz, NHβ), 5.
920 (dd, 0.7H, J = 3.3 and 11.0 Hz, H-3dα), 5.845
(dd, 0.3H, J = 3.5 and 11.0 Hz, H-3dβ), 5.577 (td, 1
H, J = 3.7 and 9.5 Hz, H-8c), 5.538 (dd, 0.7H, J = 9.2
And 9.9 Hz, H-3aα), 5.491 (ddd, 1H, J = 4.8, 10.
3 and 12.1 Hz, H-4c), 5.397 (br. D, 0.7H, J = 2.6 H
z, H-1aα), 5.370 (d, 0.7H, J = 2.9 Hz, H-4dα), 5.36
4 (d, 0.3H, J = 2.6 Hz, H-4dβ), 5.275 (t, 0.3H, J = 9.5
Hz, H-3aβ), 5.249 (dd, 0.7H, J = 2.6 and 9.9 Hz,
H-7cα), 5.241 (dd, 0.3H, J = 2.9 and 9.9 Hz, H-7c
β), 5.159 (d, 0.7H, J = 8.1 Hz, H-1dα), 5.131 (d, 0.
3H, J = 8.4 Hz, H-1dβ), 5.007 (dd, 0.7H, J = 8.1 and 1
0.3 Hz, H-2bα), 4.987 (dd, 0.3H, J = 8.1 and 10.6
Hz, H-2bβ), 4.880 (dd, 1H, J = 2.6 and 10.6 Hz, H-6
c), 4.798 (dd, 0.7H, J = 3.7 and 10.3 Hz, H-2aα), 4.
778 (dd, 0.3H, J = 8.1 and 9.9 Hz, H-2aβ), 4.692 (br.
t, 0.3H, J = 7.7 Hz, H-1aβ), 4.611 (d, 1H, J = 7.7 Hz,
H-1b), 4.332 (dd, 0.3H, J = 2.8 and 9.9 Hz, H-3b
β), 4.329 (dd, 0.7H, J = 2.6 and 10.3 Hz, H-3bα),
4.100 (t, 1H, J = 10.6 Hz, H-Sc), 3.926 (s, 0.9H, OMe
β), 3.923 (s, 2.1H, OMeα), 3.852 (t, 0.7H, J = 9.2
Hz, H-3aα), 3.829 (t, 0.3H, J = 9.5 Hz, H-3aβ), 3.5
84 (d, 0.3H, J = 2.2 Hz, H-4bβ), 3.580 (d, 0.7H, J = 2.
2 Hz, H-4bα), 3.399 (td, 0.3H, J = 8.1 and 11.0 H
z, H-2dβ), 3.338 (td, 0.7H, J = 8.1 and 10.6 Hz, H
-2dα), 2.975 (dd, 1H, J = 5.1 and 12.6 Hz, H-3ce
q), 2.246, 2.171, 2.138, 2.134, 2.109, 2.104, 2.10
1, 2.098, 2.071, 2.067, 2.028, 1.995, 1.991, 1.832
And 1.828 (16s, 36H, OAc), 1.725 (t, 1H, J = 12.5 H
z, H-3cax), and 1.190 (s, 9H, (CH 3 ) 3 C).

【0034】[0034]

【例10】化合物19の合成 化合物16及び17の混合物(32.8mg) を化合物18の合成法
と同様に行ない、化合物19(22.3mg、 69.9%)へ変換し
た。 〔α〕D +14.4°(c 0.88, CHCl3) Rf 0.39, 0.36 19:1 CHCl3-MeOH中1 H-n. m. r. データー:δH 6.237(d, 0.28H, J=7.0 H
z, NHαtrans), 6.209 (d, 0.42H, J=7.0 Hz, NHαci
s), 6.113(d, 0.12H, J=7.3 Hz, NHβtrans), 6.007(d,
0.18H, J=7.0 Hz, NHβcis), 5.914(dd, 0.28H, J=3.7
及び 11.4 Hz, H-3dαtrans), 5.868(dd, 0.42H, J=
3.3 及び 11.0 Hz, H-3dαcis), 5.846(dd,0.12H, J=
3.7 及び 11.0 Hz, H-3dβtrans), 5.792(dd, 0.18H,
J=3.7 及び 11.4 Hz, H-3dβcis), 5.392(d, 0.7H, J=
3.7 Hz, H−1aα), 5.360(br. s, 1H,H-4d), 5.155(m,
1H, H-7c), 4.975(m, 1H, H-2b), 4.795(dd, 0.7H, J=
3.7 及び 10.3 Hz, H-2aα), 4.585 (d, 0.4H, J=7.7
Hz, H-1btrans), 4.575 (d, 0.6H, J=7.7 Hz, H-1bci
s), 3.886及び 3.876(2s, 3H, OMe), 3.554(m, 1H, H-4
b),3.375(m, 1H, H-2d), 2.931(m, 1H, H-3ceq), 2.816
(m, 1.2H, シクロヘキサン環 H-1 及びH-2cis), 2.709
(q, 0.4H, J=7.3 Hz, シクロヘキサン環 H-1 or H-2tra
ns), 2.788(q, 0.4H, J=6.6 Hz, シクロヘキサン環 H-1
or H-2 trans), 2.214, 2.196, 2.163, 2.148, 2.131,
2.096, 2.092, 2.083, 2.058, 2.055, 2.030, 2.020,
2.014, 1.999, 1.986, 1.971, 1.966 及び 1.952(18
s, 36H, OAc),1.646(m, 1H, H-3cax), 及び 1.187(s,
9H, (CH3)3C).
Example 10 Synthesis of Compound 19 A mixture of Compounds 16 and 17 (32.8 mg) was converted into Compound 19 (22.3 mg, 69.9%) by the same method as in the synthesis of Compound 18 . [Α] D + 14.4 ° (c 0.88, CHCl 3 ) Rf 0.39, 0.36 19: 1 CHCl 3 in MeOH 1 Hn. Mr Data: δH 6.237 (d, 0.28H, J = 7.0 H
z, NHαtrans), 6.209 (d, 0.42H, J = 7.0 Hz, NHαci
s), 6.113 (d, 0.12H, J = 7.3 Hz, NHβtrans), 6.007 (d,
0.18H, J = 7.0 Hz, NHβcis), 5.914 (dd, 0.28H, J = 3.7
And 11.4 Hz, H-3dαtrans), 5.868 (dd, 0.42H, J =
3.3 and 11.0 Hz, H-3dαcis), 5.846 (dd, 0.12H, J =
3.7 and 11.0 Hz, H-3dβtrans), 5.792 (dd, 0.18H,
J = 3.7 and 11.4 Hz, H-3dβcis), 5.392 (d, 0.7H, J =
3.7 Hz, H−1aα), 5.360 (br.s, 1H, H-4d), 5.155 (m,
1H, H-7c), 4.975 (m, 1H, H-2b), 4.795 (dd, 0.7H, J =
3.7 and 10.3 Hz, H-2aα), 4.585 (d, 0.4H, J = 7.7
Hz, H-1btrans), 4.575 (d, 0.6H, J = 7.7 Hz, H-1bci
s), 3.886 and 3.876 (2s, 3H, OMe), 3.554 (m, 1H, H-4
b), 3.375 (m, 1H, H-2d), 2.931 (m, 1H, H-3ceq), 2.816
(m, 1.2H, cyclohexane ring H-1 and H-2cis), 2.709
(q, 0.4H, J = 7.3 Hz, cyclohexane ring H-1 or H-2tra
ns), 2.788 (q, 0.4H, J = 6.6 Hz, cyclohexane ring H-1
or H-2 trans), 2.214, 2.196, 2.163, 2.148, 2.131,
2.096, 2.092, 2.083, 2.058, 2.055, 2.030, 2.020,
2.014, 1.999, 1.986, 1.971, 1.966 and 1.952 (18
s, 36H, OAc), 1.646 (m, 1H, H-3cax), and 1.187 (s,
9H, (CH 3 ) 3 C).

【0035】[0035]

【例11】 化合物20の合成 化合物18(12.7 mg、 7.7 μmol)をジクロロエタン(0.2
ml)に溶解し、トリクロロアセトニトリル(10μl 、9
7.7μmol)および DBU (1.8 μl 、11.6μmol)を0℃で
加え、同温度で3時間攪拌した。反応液をそのままフラ
ッシュクロマトグラフィー(C-300、 1.0 g、 3:2 トルエ
ン−THF)にて精製し、化合物20(13.8mg、99.3%)を得
た。 〔α〕D +40.2°(c 0.92, CHCl3) Rf 0.50 11:9 トルエン−THF 中1 H-n. m. r. データー:δH(CDCl3) 8.650(s, 1H, C=N
H), 7.818(m, 2H, 芳香族水素), 7.735(m, 2H, 芳香族
水素), 6.522(d, 1H, J=3.7 Hz, H-1a), 6.020(d,1H, J
=7.3 Hz, NH), 5.842(dd, 1H, J=3.3 及び 11.0 Hz, H
-3d), 5.573(m, 2H, H-8c 及び H-3a), 5.495(ddd, 1
H, J=4.8, 10.3 及び 12.1 Hz, H-4c), 5.366(d, 1H,
J=3.3 Hz, H-4d), 5.241(dd, 1H, J=2.9 及び 9.9 Hz,
H-7c), 5.133(d, 1H, J=8.1 Hz, H-1d), 5.076(dd, 1
H, J=3.7 及び 10.3 Hz, H-2a), 5.016(dd, 1H, J=7.7
及び 9.9 Hz, H-2b), 4.875 (dd, 1H, J=2.9 及び 1
1.0 Hz,H-6c), 4.659(d, 1H, J=7.7 Hz, H-1b), 4.336
(dd, 1H, J=2.6 及び 10.3 Hz,H-3b), 4.267(dd, 1H,
J=5.5 及び 11.4 Hz, H-9c), 4.102(t, 1H, J=10.3 H
z,H-5c), 3.591(br. d, 1H, J=1.8 Hz, H-4b), 3.415(t
d. 1H, J=7.7 及び 10.6Hz, H-2d), 2.961(dd, 1H, J=
4.8 及び 12.8 Hz, H-3ceq), 2.260, 2.173, 2.142,
2.110, 2.093, 2.073, 2.071, 2.029, 2.014, 1.992,
1.943 及び 1.831(12s, 36H, 12OAc), 1.729(t, 1H, J
=12.8 Hz, H-3cax), 及び 1.141(s, 9H, (CH3)3C).
Example 11 Synthesis of Compound 20 Compound 18 (12.7 mg, 7.7 μmol) was treated with dichloroethane (0.2
ml) and dissolve in trichloroacetonitrile (10 μl, 9
7.7 μmol) and DBU (1.8 μl, 11.6 μmol) were added at 0 ° C., and the mixture was stirred at the same temperature for 3 hours. The reaction solution was directly purified by flash chromatography (C-300, 1.0 g, 3: 2 toluene-THF) to obtain Compound 20 (13.8 mg, 99.3%). [Α] D + 40.2 ° (c 0.92, CHCl 3 ) Rf 0.50 11: 9 Toluene-THF in 1 Hn. Mr Data: δH (CDCl 3 ) 8.650 (s, 1H, C = N
H), 7.818 (m, 2H, aromatic hydrogen), 7.735 (m, 2H, aromatic hydrogen), 6.522 (d, 1H, J = 3.7 Hz, H-1a), 6.020 (d, 1H, J
= 7.3 Hz, NH), 5.842 (dd, 1H, J = 3.3 and 11.0 Hz, H
-3d), 5.573 (m, 2H, H-8c and H-3a), 5.495 (ddd, 1
H, J = 4.8, 10.3 and 12.1 Hz, H-4c), 5.366 (d, 1H,
J = 3.3 Hz, H-4d), 5.241 (dd, 1H, J = 2.9 and 9.9 Hz,
H-7c), 5.133 (d, 1H, J = 8.1 Hz, H-1d), 5.076 (dd, 1
H, J = 3.7 and 10.3 Hz, H-2a), 5.016 (dd, 1H, J = 7.7
And 9.9 Hz, H-2b), 4.875 (dd, 1H, J = 2.9 and 1
1.0 Hz, H-6c), 4.659 (d, 1H, J = 7.7 Hz, H-1b), 4.336
(dd, 1H, J = 2.6 and 10.3 Hz, H-3b), 4.267 (dd, 1H,
J = 5.5 and 11.4 Hz, H-9c), 4.102 (t, 1H, J = 10.3 H
z, H-5c), 3.591 (br. d, 1H, J = 1.8 Hz, H-4b), 3.415 (t
d. 1H, J = 7.7 and 10.6Hz, H-2d), 2.961 (dd, 1H, J =
4.8 and 12.8 Hz, H-3ceq), 2.260, 2.173, 2.142,
2.110, 2.093, 2.073, 2.071, 2.029, 2.014, 1.992,
1.943 and 1.831 (12s, 36H, 12OAc), 1.729 (t, 1H, J
= 12.8 Hz, H-3cax), and 1.141 (s, 9H, (CH 3 ) 3 C).

【0036】[0036]

【例12】 化合物21の合成 化合物19(22.3 mg) を化合物20の合成法と同様に行ない
化合物21 (23.0 mg,94.0%) へ変換した。 〔α〕D +26.3°(c 0.76, CHCl3) Rf 0.35 13 : 7 トルエン−THF 中1 H-n. m. r. データー:δH(CDCl3) 8.646(s, 1H, C=N
H), 6.518(d, 1H, J=3.7Hz, H-1a), 5.981(d, 0.4H, J=
7.3 Hz, NHtrans), 5.984(d, 0.6H, J=7.3 Hz, NHcis),
5.856(dd, 0.4H, J=3.3 及び 11.4 Hz, H-3dtrans),
5.797(dd, 0.6H,J=3.3 及び 11.0 Hz, H-3dcis), 5.568
(m, 1.6H, H-3a 及び H-8ccis), 5.479(td, 0.4H, J=3.
3 及び 9.5 Hz, H-8ctrans), 5.359(br. s, 1H, H-4
d), 5.153(dd, 0.6H, J=2.9 及び 9.9 Hz, H-7ccis),
5.121(dd, 0.4H, J=2.2 及び 9.6 Hz, H-7ctrans), 5.
098(d, 1H, J=8.4 Hz, H-1d), 5.072(dd, 1H, J=3.7
及び 10.3 Hz, H-2a), 4.989(dd, 0.4H, J=7.3 及び
9.5 Hz, H-2btrans), 4.984(dd,0.6H, J=7.7 及び 10.
3 Hz, H-2bcis), 4.793(dd, 0.4H, J=3.7 及び 10.6 H
z, H-6ctrans), 4.786(dd, 0.6H, J=2.9 及び 10.6 Hz,
H-6ccis), 4.633(d, 0.4H, J=7.7 Hz, H-1btrans), 4.
623(d, 0.6H, J=7.7 Hz, H-1bcis), 4.317(dd, 0.4H, J
=2.6 及び 9.9 Hz, H-3btrans), 4.275(dd, 0.6H, J=2.
6 及び 10.3 Hz,H-3bcis), 3.890(s, 1.8H, OMecis),
3.880(s, 1.2H, OMetrans), 3.563(br. s,1H, H-4b),
3.435(td, 0.6H, J=8.1 及び 11.0 Hz, H-2dcis), 3.
379(td, 0.4H, J=7.3 及び 11.0 Hz, H-2dtrans), 2.93
6(dd, 0.6H, J=4.8 及び 12.8 Hz,H-3ceqcis), 2.900(d
d, 0.4H, J=5.1 及び 13.2 Hz, H-3ceqtrans), 2.815
(m, 1.2H, シクロヘキサン環 H-1及び H-2cis), 2.709
(q, 0.4H, J=7.7 Hz,シクロヘキサン環 H-1 or H-2tran
s), 2.638(q, 0.4H, J=6.6 Hz, シクロヘキサン環 H-1o
r H-2 trans), 2.356, 2.230, 2.211, 2.166, 2.151,
2.138, 2.099, 2.077,2.066, 2.062, 2.022, 2.015, 2.
000, 1.994, 1.989, 1.967, 及び 1.953(17s,36H, OA
c), 及び 1.139(s, 9H, (CH3)3C).
Example 12 Synthesis of compound 21 Compound 19 (22.3 mg) was converted to compound 21 (23.0 mg, 94.0%) by the same method as for the synthesis of compound 20 . [Α] D + 26.3 ° (c 0.76, CHCl 3 ) Rf 0.35 13: 7 Toluene-THF in 1 Hn. Mr Data: δH (CDCl 3 ) 8.646 (s, 1H, C = N
H), 6.518 (d, 1H, J = 3.7Hz, H-1a), 5.981 (d, 0.4H, J =
7.3 Hz, NHtrans), 5.984 (d, 0.6H, J = 7.3 Hz, NHcis),
5.856 (dd, 0.4H, J = 3.3 and 11.4 Hz, H-3dtrans),
5.797 (dd, 0.6H, J = 3.3 and 11.0 Hz, H-3dcis), 5.568
(m, 1.6H, H-3a and H-8ccis), 5.479 (td, 0.4H, J = 3.
3 and 9.5 Hz, H-8ctrans), 5.359 (br.s, 1H, H-4
d), 5.153 (dd, 0.6H, J = 2.9 and 9.9 Hz, H-7ccis),
5.121 (dd, 0.4H, J = 2.2 and 9.6 Hz, H-7ctrans), 5.
098 (d, 1H, J = 8.4 Hz, H-1d), 5.072 (dd, 1H, J = 3.7
And 10.3 Hz, H-2a), 4.989 (dd, 0.4H, J = 7.3 and
9.5 Hz, H-2btrans), 4.984 (dd, 0.6H, J = 7.7 and 10.
3 Hz, H-2bcis), 4.793 (dd, 0.4H, J = 3.7 and 10.6 H
z, H-6ctrans), 4.786 (dd, 0.6H, J = 2.9 and 10.6 Hz,
H-6ccis), 4.633 (d, 0.4H, J = 7.7 Hz, H-1btrans), 4.
623 (d, 0.6H, J = 7.7 Hz, H-1bcis), 4.317 (dd, 0.4H, J
= 2.6 and 9.9 Hz, H-3btrans), 4.275 (dd, 0.6H, J = 2.
6 and 10.3 Hz, H-3bcis), 3.890 (s, 1.8H, OMecis),
3.880 (s, 1.2H, OMetrans), 3.563 (br.s, 1H, H-4b),
3.435 (td, 0.6H, J = 8.1 and 11.0 Hz, H-2dcis), 3.
379 (td, 0.4H, J = 7.3 and 11.0 Hz, H-2dtrans), 2.93
6 (dd, 0.6H, J = 4.8 and 12.8 Hz, H-3ceqcis), 2.900 (d
d, 0.4H, J = 5.1 and 13.2 Hz, H-3ceqtrans), 2.815
(m, 1.2H, cyclohexane ring H-1 and H-2cis), 2.709
(q, 0.4H, J = 7.7 Hz, cyclohexane ring H-1 or H-2tran
s), 2.638 (q, 0.4H, J = 6.6 Hz, cyclohexane ring H-1o
r H-2 trans), 2.356, 2.230, 2.211, 2.166, 2.151,
2.138, 2.099, 2.077, 2.066, 2.062, 2.022, 2.015, 2.
000, 1.994, 1.989, 1.967, and 1.953 (17s, 36H, OA
c), and 1.139 (s, 9H, (CH 3 ) 3 C).

【0037】[0037]

【例13】 化合物23の合成 化合物20(13.8 mg、 8.5 μmol)、22(12.9mg、 17.1μmo
l)及びモレキュラーシーブス 4A(51mg) のCHCl3 (0.7
ml )溶液に、−18°で BF3・OEt2(2.1μl 、17.1μmo
l)を加え、同温度で1時間攪拌した。更に0°で2時間
攪拌後、反応液をCHCl3 (20ml)で希釈し、セライト濾過
した。濾液を飽和重曹水(20ml)で洗浄し、洗液をクロロ
ホルム(20ml x 2)で再抽出した。クロロホルム層を合わ
せ、飽和食塩水(40ml)で洗浄し、無水硫酸マグネシウム
で乾燥後、溶媒を減圧留去した。残渣をフラッシュクロ
マトグラフィー(C-300, 3g, 39:1 CHCl3-MeOH) にて精
製し、化合物23(6.4 mg、34.0%)を得た。 〔α〕D +17.8°(c 0.39, CHCl3) Rf 0.34 13 : 7 トルエン−THF 中1 H-n. m. r. データー:δH(CDCl3) 7.993(dd, 2H, J=
1.5 及び 7.0 Hz, C6H5CO), 7.819(m, 2H, 芳香族水
素), 7.735(m, 2H, 芳香族水素), 1.541(tt, 1H, J=1.5
及び 7.3 Hz, C6H5CO), 7.422(t, 2H, J=7.7 Hz, C6H
5CO), 6.236(d, 1H,J=7.3 Hz, NH-2d), 5.869(td ,1H,
J=6.6 及び 14.7 Hz, H-5cer), 5.847 (dd, 1H, J=3.3
及び 11.4 Hz, H-3d), 5.756(d, 1H, J=9.5 Hz, NHce
r), 5.569(td,1H, J=3.3 及び 9.5 Hz H-8c), 5.544
(t, 1H, J=7.3 Hz, H-3cer), 5.460(dd,1H, J=7.7 及
び 15.4 Hz, H-4cer), 5.360(d, 1H, J=2.9 Hz, H-4d),
5.234(dd, 1H, J=2.6 及び 9.9 Hz, H-7c), 5.185(t,
1H, J=9.5 Hz, H-3a), 5.125(d,1H, J=8.4 Hz, H-1d),
4.963(dd, 1H, J=7.7 及び 10.3 Hz, H-2b), 4.926(d
d,1H, J=7.7 及び 9.9 Hz, H-2a), 4.878(dd, 1H, J=
2.6 及び 10.6 Hz, H-6c),4.574(d, 1H, J=7.7 Hz, H-1
b), 4.456(m, 1H, H-2cer), 4.419(d, 1H, J=7.7Hz, H-
1a), 4.321(dd, 1H, J=2.6 及び 9.9 Hz, H-3b), 4.09
5(t, 1H, J=10.5Hz, H-5c), 3.923(s, 3H, OMe), 3.829
(t, 1H, J=9.5 Hz, H-3a), 3.600(dd, 1H, J=4.0 及び
9.9 Hz, H-1cer), 3.577(d, 1H, J=2.2 Hz, H-4b), 3.5
27(m, 1H,H-5a), 3.377(td, 1H, J=7.7 及び 11.0 Hz,
H-2d), 2.947(dd, 1H, J=4.8 及び 12.8 Hz, H-3ceq),
2.210, 2.173, 2.132, 2.124, 2.091, 2.057, 2.027,
1.984, 1.976, 1.947, 1.893 及び 1.828(12s, 36H, 1
2OAc), 1.714(t, 1H, 12.7Hz, H-3cax), 1.151(S, 9H,
(CH3)3C), 0.880(t, 3H, J=7.3 Hz, (CH 2CH3 ),及び 0.
876(t, 3H, J=7.0 Hz, CH2 CH3).
Example 13 Synthesis of Compound 23 Compound 20 (13.8 mg, 8.5 μmol), 22 (12.9 mg, 17.1 μmo)
l) and molecular sieves 4A (51 mg) of CHCl 3 (0.7
BF 3 OEt 2 (2.1 μl, 17.1 μmo) at −18 °
l) was added, and the mixture was stirred at the same temperature for 1 hour. After stirring at 0 ° for 2 hours, the reaction solution was diluted with CHCl 3 (20 ml) and filtered through Celite. The filtrate was washed with saturated aqueous sodium hydrogen carbonate (20 ml), and the washings were re-extracted with chloroform (20 ml x 2). The chloroform layers were combined, washed with saturated brine (40 ml), dried over anhydrous magnesium sulfate, and the solvent was evaporated under reduced pressure. The residue was purified by flash chromatography (C-300, 3g, 39: 1 CHCl 3 -MeOH) to obtain compound 23 (6.4 mg, 34.0%). [Α] D + 17.8 ° (c 0.39, CHCl 3 ) Rf 0.34 13: 7 Toluene-THF in 1 Hn. Mr Data: δH (CDCl 3 ) 7.993 (dd, 2H, J =
1.5 and 7.0 Hz, C 6 H 5 CO), 7.819 (m, 2H, aromatic hydrogen), 7.735 (m, 2H, aromatic hydrogen), 1.541 (tt, 1H, J = 1.5
And 7.3 Hz, C 6 H 5 CO), 7.422 (t, 2H, J = 7.7 Hz, C 6 H
5 CO), 6.236 (d, 1H, J = 7.3 Hz, NH-2d), 5.869 (td, 1H,
J = 6.6 and 14.7 Hz, H-5cer), 5.847 (dd, 1H, J = 3.3
And 11.4 Hz, H-3d), 5.756 (d, 1H, J = 9.5 Hz, NHce
r), 5.569 (td, 1H, J = 3.3 and 9.5 Hz H-8c), 5.544
(t, 1H, J = 7.3 Hz, H-3cer), 5.460 (dd, 1H, J = 7.7 and 15.4 Hz, H-4cer), 5.360 (d, 1H, J = 2.9 Hz, H-4d),
5.234 (dd, 1H, J = 2.6 and 9.9 Hz, H-7c), 5.185 (t,
1H, J = 9.5 Hz, H-3a), 5.125 (d, 1H, J = 8.4 Hz, H-1d),
4.963 (dd, 1H, J = 7.7 and 10.3 Hz, H-2b), 4.926 (d
d, 1H, J = 7.7 and 9.9 Hz, H-2a), 4.878 (dd, 1H, J =
2.6 and 10.6 Hz, H-6c), 4.574 (d, 1H, J = 7.7 Hz, H-1
b), 4.456 (m, 1H, H-2cer), 4.419 (d, 1H, J = 7.7Hz, H-
1a), 4.321 (dd, 1H, J = 2.6 and 9.9 Hz, H-3b), 4.09
5 (t, 1H, J = 10.5Hz, H-5c), 3.923 (s, 3H, OMe), 3.829
(t, 1H, J = 9.5 Hz, H-3a), 3.600 (dd, 1H, J = 4.0 and
9.9 Hz, H-1cer), 3.577 (d, 1H, J = 2.2 Hz, H-4b), 3.5
27 (m, 1H, H-5a), 3.377 (td, 1H, J = 7.7 and 11.0 Hz,
H-2d), 2.947 (dd, 1H, J = 4.8 and 12.8 Hz, H-3ceq),
2.210, 2.173, 2.132, 2.124, 2.091, 2.057, 2.027,
1.984, 1.976, 1.947, 1.893 and 1.828 (12s, 36H, 1
2OAc), 1.714 (t, 1H, 12.7Hz, H-3cax), 1.151 (S, 9H,
(CH 3 ) 3 C), 0.880 (t, 3H, J = 7.3 Hz, (CH 2 CH 3 ), and 0.
876 (t, 3H, J = 7.0 Hz, CH 2 CH 3 ) .

【0038】[0038]

【例14 】 化合物24の合成 化合物21(21.8 mg) と22(20.1 mg)とを化合物23の合成
法と同様に縮合し、化合物24(9.4 mg、32.3%)を得た。 〔α〕D +3.9°(c 0.52, CHCl3) Rf 0.40 13 : 7 トルエン−THF 中1 H-n. m. r. データー:δH(CDCl3) 7.991(d, 2H, J=7.
3 Hz, C6H5CO), 7.542(t, 1H, J=7.7 Hz, C6H5CO), 7.4
24(t, 2H, J=7.7 Hz, C6H5CO), 6.183(d, 0.4H,J=7.7 H
z, NH-2dtrans), 6.144(d, 0.6H, J=7.3 Hz, NH-2dci
s), 5.867(td 1H,J=6.6 及び 15.0 Hz, H-5cer), 5.797
(dd, 0.6H, J=3.3 及び 11.0 Hz, H-3dcis), 5.750(d,
1H, J=9.2 Hz, NHcer), 5.542(t, 1H, J=7.5 Hz, H-3c
er), 5.459(dd, 1H, J=7.3 及び 15.0 Hz, H-4cer),
5.429(m, 1H, H-4c), 5.353(br. d,1H, J=2.6 Hz, H-4
d), 5.173(t, 1H, J=9.2 Hz, H-3a), 5.089(d, 1H, J=
8.1 Hz, H-1d), 4.928(m, 2H, H-2a 及び H-2b), 4.79
9(dd, 0.4H, J=2.6 及び 11.0Hz, H-6ctrans), 4.790(d
d, 0.6H, J=2.9 及び 10.6 Hz, H-6ccis), 4.554(d,0.
4H, J=7.0 Hz, H-1btrans), 4.542(d, 0.6H, J=8.1 Hz,
H-1bcis), 4.454(m,1H, H-2cer), 4.413(d, 1H, J=8.1
Hz, H-1a), 4.301(br. d, 1H, J=10.3 Hz, H-3b), 3.8
84(s, 1.8H, 0Mecis), 3.875(s, 1.2H, OMetrans), 3.8
18(t, 1H, J=9.7 Hz, H-4a), 3.596(dd, 1H, J=3.9 及
び 10.1 Hz, H-1cer), 3.551(br. s, 1H, H-4b), 3.507
(m, 1H, H-5a), 3.379(m, 1H, H-2d), 2.920(dd, 0.6H,
J=4.4及び 12.8 Hz, H-3ceqcis), 2.881(dd, 0.4H, J=
5.1 及び 12.8 Hz, H-3ceqtrans), 2.815(m, 1.2H, シ
クロヘキサン環 H-1及び H-2cis), 2.709 (q, 0.4H, J=
7.7 Hz, シクロヘキサン環 H-1 or H-2trans), 2637(q,
0.4H, J=6.6 Hz, シクロヘキサン環 H-1 or H-2tran
s), 2.175, 2.164, 2.160, 2.156, 2.151, 2.128,2.11
2, 2.074, 2.048, 2.046, 2.020, 2.006, 1.980, 1.96
2, 1.956, 1.954, 1.948, 1.889, 及び 1.885(19s, 36
H, OAc), 1.147(s, 9H, (CH3)3C), 0.879(t,3H, J=6.5
Hz, CH 2CH3), 及び 0.878(t, 3H, J=7.0 Hz, CH2 CH3).
Example 14 Synthesis of Compound 24 Compound 21 (21.8 mg) and 22 (20.1 mg) were condensed in the same manner as in the synthesis method of Compound 23 to obtain Compound 24 (9.4 mg, 32.3%). (Α) D + 3.9 ° (c 0.52, CHCl 3 ) Rf 0.40 13: 7 Toluene-THF in 1 Hn. Mr Data: δH (CDCl 3 ) 7.991 (d, 2H, J = 7.
3 Hz, C 6 H 5 CO), 7.542 (t, 1H, J = 7.7 Hz, C 6 H 5 CO), 7.4
24 (t, 2H, J = 7.7 Hz, C 6 H 5 CO), 6.183 (d, 0.4H, J = 7.7 H
z, NH-2dtrans), 6.144 (d, 0.6H, J = 7.3 Hz, NH-2dci
s), 5.867 (td 1H, J = 6.6 and 15.0 Hz, H-5cer), 5.797
(dd, 0.6H, J = 3.3 and 11.0 Hz, H-3dcis), 5.750 (d,
1H, J = 9.2 Hz, NHcer), 5.542 (t, 1H, J = 7.5 Hz, H-3c
er), 5.459 (dd, 1H, J = 7.3 and 15.0 Hz, H-4cer),
5.429 (m, 1H, H-4c), 5.353 (br. D, 1H, J = 2.6 Hz, H-4
d), 5.173 (t, 1H, J = 9.2 Hz, H-3a), 5.089 (d, 1H, J =
8.1 Hz, H-1d), 4.928 (m, 2H, H-2a and H-2b), 4.79
9 (dd, 0.4H, J = 2.6 and 11.0Hz, H-6ctrans), 4.790 (d
d, 0.6H, J = 2.9 and 10.6 Hz, H-6ccis), 4.554 (d, 0.
4H, J = 7.0 Hz, H-1btrans), 4.542 (d, 0.6H, J = 8.1 Hz,
H-1bcis), 4.454 (m, 1H, H-2cer), 4.413 (d, 1H, J = 8.1
Hz, H-1a), 4.301 (br. D, 1H, J = 10.3 Hz, H-3b), 3.8
84 (s, 1.8H, 0Mecis), 3.875 (s, 1.2H, OMetrans), 3.8
18 (t, 1H, J = 9.7 Hz, H-4a), 3.596 (dd, 1H, J = 3.9 and 10.1 Hz, H-1cer), 3.551 (br.s, 1H, H-4b), 3.507
(m, 1H, H-5a), 3.379 (m, 1H, H-2d), 2.920 (dd, 0.6H,
J = 4.4 and 12.8 Hz, H-3ceqcis), 2.881 (dd, 0.4H, J =
5.1 and 12.8 Hz, H-3ceqtrans), 2.815 (m, 1.2H, cyclohexane ring H-1 and H-2cis), 2.709 (q, 0.4H, J =
7.7 Hz, cyclohexane ring H-1 or H-2trans), 2637 (q,
0.4H, J = 6.6 Hz, cyclohexane ring H-1 or H-2tran
s), 2.175, 2.164, 2.160, 2.156, 2.151, 2.128, 2.11
2, 2.074, 2.048, 2.046, 2.020, 2.006, 1.980, 1.96
2, 1.956, 1.954, 1.948, 1.889, and 1.885 (19s, 36
H, OAc), 1.147 (s , 9H, (CH 3) 3 C), 0.879 (t, 3H, J = 6.5
Hz, CH 2 CH 3 ) , and 0.878 (t, 3H, J = 7.0 Hz, CH 2 CH 3 ) .

【0039】[0039]

【例15】 化合物25の合成 ヨウ化リチウム(3.5 mg、26.2μmol)を90°オイルバス
上で21時間真空乾燥し、これに化合物23(4.0 mg、1.8
μmol)の無水ピリジン(0.20ml)溶液を加え、110°で
2時間攪拌した。反応液をゲル濾過(セファデックス L
H-20, 5ml, MeOH)精製後、フラッシュクロマトグラフィ
ー(Wako Gel FC-40, 0.6g, 9:1 CHCl3-MeOH)にて再精
製し、化合物25(3.2 mg、80.3%)を得た。 〔α〕D +19.0°(c 0.21, CHCl3) Rf 0.53 17 : 3 CHCl3-MeOH中1 H-n. m. r. データー:δH(CD3OD) 7.999(d, 2H, J=7.
3 Hz, C6H5CO), 7.862(m, 2H, 芳香族水素), 7.806(m,
2H, 芳香族水素), 7.591(t, 1H, J=7.3 Hz, C6H5CO),
7.460(t, 2H, J=7.7 Hz, C6H5CO), 5.872(td, 1H, J=7.
3 及び 15.0 Hz,H-5ccer), 5.726 (dt, 1H, J=5.1 及
び 11.0 Hz, H-4c), 5.561(t, 1H, J=6.8Hz, H-3cer),
5.507(dd, 1H, J=7.7 及び 15.0 Hz, H-4cer), 5.311
(d, 1H, J=2.9 Hz, H-4d), 2.872(dd, 1H, J=5.1 及び
11.0 Hz, H-3ceq), 2.152, 2.146,2.143, 2.110, 2.06
2, 2.038, 1.998, 1.987, 1.974, 1.912(6H) 及び 1.77
8(11S, 36H, 120Ac), 1.580(t, 1H, J=11.0, Hz, H-3ca
x), 1.152(S, 9H, (CH3)3C), 0.896(t, 3H, J=7.3 Hz,
CH 2CH3 ), 及び 0.894(t, 3H, J=7.0 Hz, CH 2CH3 ).
Example 15 Synthesis of Compound 25 Lithium iodide (3.5 mg, 26.2 μmol) was vacuum dried on a 90 ° oil bath for 21 hours, and Compound 23 (4.0 mg, 1.8 mg) was added thereto.
A solution of μmol) in anhydrous pyridine (0.20 ml) was added, and the mixture was stirred at 110 ° for 2 hours. Gel filtration of the reaction mixture (Sephadex L
After purification with H-20, 5 ml, MeOH), re-purification with flash chromatography (Wako Gel FC-40, 0.6 g, 9: 1 CHCl 3 -MeOH) gave compound 25 (3.2 mg, 80.3%). . [Α] D + 19.0 ° (c 0.21, CHCl 3 ) Rf 0.53 17: 3 CHCl 3 -MeOH in Hn 1 mr. Data: δH (CD 3 OD) 7.999 (d, 2H, J = 7.
3 Hz, C 6 H 5 CO), 7.862 (m, 2H, aromatic hydrogen), 7.806 (m,
2H, aromatic hydrogen), 7.591 (t, 1H, J = 7.3 Hz, C 6 H 5 CO),
7.460 (t, 2H, J = 7.7 Hz, C 6 H 5 CO), 5.872 (td, 1H, J = 7.
3 and 15.0 Hz, H-5ccer), 5.726 (dt, 1H, J = 5.1 and 11.0 Hz, H-4c), 5.561 (t, 1H, J = 6.8Hz, H-3cer),
5.507 (dd, 1H, J = 7.7 and 15.0 Hz, H-4cer), 5.311
(d, 1H, J = 2.9 Hz, H-4d), 2.872 (dd, 1H, J = 5.1 and
11.0 Hz, H-3ceq), 2.152, 2.146,2.143, 2.110, 2.06
2, 2.038, 1.998, 1.987, 1.974, 1.912 (6H) and 1.77
8 (11S, 36H, 120Ac), 1.580 (t, 1H, J = 11.0, Hz, H-3ca
x), 1.152 (S, 9H, (CH 3 ) 3 C), 0.896 (t, 3H, J = 7.3 Hz,
CH 2 CH 3 ), and 0.894 (t, 3H, J = 7.0 Hz, CH 2 CH 3 ).

【0040】[0040]

【例16】 化合物26の合成 化合物24(5.9 mg) を化合物25の合成法と同様に行な
い、化合物26(5.8 mg、98.6%)へ変換した。 〔α〕D +12.9°(c 0.39, CHCl3) Rf 0.48 17 : 3 CHCl3-MeOH中1 H-n. m. r. データー:δH(CO3OD) 7.997(d, 2H, J=8.
0 Hz, C6H5CO), 7.592(t, 1H, J=7.3 Hz, C6H5CO), 7.4
60(d, 2H, J=7.7 Hz, C6H5CO), 5.880(td, 1H, J=6.2
及び 15.4 Hz, H-5cer), 5.664(m, 1H, H-4c), 5.560
(t, 1H, J=7.7 Hz,H-3cer), 5.497(dd, 1H, J=6.6 及
び 15.4 Hz, H-4cer), 5.434(m, 0.6H, H-8ccis), 5.34
8(m, 0.4H, H-8ctrans), 5.305(d, 1H, J=2.6 Hz, H-4
d), 4.635(d,2H, J=8.1 Hz, H-1a 及び H-1b), 2.166,
2.140, 2.129, 2.101, 2.073, 2.032, 2.029, 2.019,
2.001, 1.996, 1.965, 1.961, 1.934 及び 1.914 (14s,
36H,0Ac), 1.149(s, 9H,(CH3)3C), 0.897(t, 3H, J=6.
4 Hz, CH 2CH 3), 及び 0.895(t, 3H, J=6.4 Hz, CH 2C
H 3).
Example 16 Synthesis of compound 26 Compound 24 (5.9 mg) was converted into compound 26 (5.8 mg, 98.6%) by the same method as for the synthesis of compound 25 . [Α] D + 12.9 ° (c 0.39, CHCl 3) Rf 0.48 17: 3 CHCl 3 -MeOH in 1 Hn mr data:. ΔH (CO 3 OD) 7.997 (d, 2H, J = 8.
0 Hz, C 6 H 5 CO), 7.592 (t, 1H, J = 7.3 Hz, C 6 H 5 CO), 7.4
60 (d, 2H, J = 7.7 Hz, C 6 H 5 CO), 5.880 (td, 1H, J = 6.2
And 15.4 Hz, H-5cer), 5.664 (m, 1H, H-4c), 5.560
(t, 1H, J = 7.7 Hz, H-3cer), 5.497 (dd, 1H, J = 6.6 and 15.4 Hz, H-4cer), 5.434 (m, 0.6H, H-8ccis), 5.34
8 (m, 0.4H, H-8ctrans), 5.305 (d, 1H, J = 2.6 Hz, H-4
d), 4.635 (d, 2H, J = 8.1 Hz, H-1a and H-1b), 2.166,
2.140, 2.129, 2.101, 2.073, 2.032, 2.029, 2.019,
2.001, 1.996, 1.965, 1.961, 1.934 and 1.914 (14s,
36H, 0Ac), 1.149 (s , 9H, (CH 3) 3 C), 0.897 (t, 3H, J = 6.
4 Hz, CH 2 CH 3 ), and 0.895 (t, 3H, J = 6.4 Hz, CH 2 C
H 3 ).

【0041】[0041]

【例17】 化合物27の合成 A法:化合物25(1.7 mg、0.8 μmol)を40% メチルアミ
ン−MeOH溶液(0.4ml)に溶解し、室温で50時間攪拌し
た。反応液を減圧乾固し、残渣に 1N-NaOH(16 μl)を加
え、ゲル濾過(セファデックス LH-20, 10ml、5:4:1 CH
Cl3-MeOH-H2O) 精製し、化合物27(0.7 mg、63.1%)を得
た。
Example 17 Synthesis of Compound 27 Method A: Compound 25 (1.7 mg, 0.8 μmol) was dissolved in 40% methylamine-MeOH solution (0.4 ml) and stirred at room temperature for 50 hours. The reaction mixture was evaporated to dryness under reduced pressure, 1N-NaOH (16 μl) was added to the residue, and gel filtration (Sephadex LH-20, 10 ml, 5: 4: 1 CH) was used.
Cl 3 —MeOH—H 2 O) was purified to obtain Compound 27 (0.7 mg, 63.1%).

【0042】B法:化合物26(2.8 mg 、1.3 μmol)をEt
OH(0.2 ml)に溶解し、MeNHNH2(0.4ml) を加え、75゜で4
8時間攪拌した。反応液を減圧乾固し、残渣を HPTLC
(メルク社製 Silica Gel 60 F254, 5:4:1 CHCl3-MeOH-
H2O)で精製後、1N-NaOH(13μ1)を加え、ゲル濾過(セフ
ァデックス LH-20, 10ml、5:4:1 CHCl3-MeOH-H2O) 精製
し、化合物27(0.8 mg、43.8%)を得た。 〔α〕D −8.8°(c 0.05, ピリジン) Rf 0.29 5:4:1 CHCl3-MeOH-H2O 中 マススペクトル: m/z 1425 (M-H)- 1 H-n. m. r. データー:δH(r:r CDCl3-CD3OD), 5.692
(td, 1H, J=6.6 及び 15.4 Hz, H-5cer), 5.455(dd, 1
H, J=7.3 及び 15.4 Hz, H-4cer), 4.844(d, 1H,J=8.4
Hz, H-1d), 4.407(d, 1H, J=8.1 Hz, H-1b), 4.291(d,
1H, J=7.7 Hz, H-1a), 4.095(t, 1H, J=7.7 Hz, H-3ce
r), 2.778(t, 1H, J=9.7 Hz, H-5c), 2.681(dd, 1H, J=
4.8 及び 12.5 Hz, H-3ceq), 2.176(t, 2H, J=7.7 Hz,
NHCOCH 2),2.037(s, 3H, NH Ac), 1.829(t, 1H, J=12.1
Hz, H-3cax), 及び 0.891(t, 6H,J=6.8 Hz, 2CH 2CH 3)
.
Method B: Compound 26 (2.8 mg, 1.3 μmol) was added with Et.
Dissolve in OH (0.2 ml), add MeNHNH 2 (0.4 ml), and add 4 at 75 °.
It was stirred for 8 hours. The reaction mixture was evaporated to dryness under reduced pressure, and the residue was HPTLC.
(Merck Silica Gel 60 F 254, 5: 4: 1 CHCl 3 -MeOH-
H 2 O), 1N-NaOH (13 μ1) was added, and gel filtration (Sephadex LH-20, 10 ml, 5: 4: 1 CHCl 3 -MeOH-H 2 O) was used to purify compound 27 (0.8 mg). , 43.8%). [Α] D -8.8 ° (c 0.05, pyridine) Rf 0.29 5: 4: 1 CHCl 3 -MeOH-H 2 O in mass spectrum: m / z 1425 (MH) - 1 Hn mr data:. ΔH (r: r CDCl 3 -CD 3 OD), 5.692
(td, 1H, J = 6.6 and 15.4 Hz, H-5cer), 5.455 (dd, 1
H, J = 7.3 and 15.4 Hz, H-4cer), 4.844 (d, 1H, J = 8.4
Hz, H-1d), 4.407 (d, 1H, J = 8.1 Hz, H-1b), 4.291 (d,
1H, J = 7.7 Hz, H-1a), 4.095 (t, 1H, J = 7.7 Hz, H-3ce
r), 2.778 (t, 1H, J = 9.7 Hz, H-5c), 2.681 (dd, 1H, J =
4.8 and 12.5 Hz, H-3ceq), 2.176 (t, 2H, J = 7.7 Hz,
NHCO CH 2 ), 2.037 (s, 3H, NH Ac ), 1.829 (t, 1H, J = 12.1
Hz, H-3cax), and 0.891 (t, 6H, J = 6.8 Hz, 2CH 2 CH 3 ).
.

フロントページの続き (72)発明者 冨田 謙吉 東京都新宿区西新宿2−1−1 メクト株 式会社内 (72)発明者 小川 智也 東京都武蔵野市吉祥寺北町3−6−6−3 −101Front Page Continuation (72) Inventor Kenkichi Tomita 2-11-1, Nishishinjuku, Shinjuku-ku, Tokyo Mect Co., Ltd. (72) Inventor Tomoya Ogawa 3-6-6-3-101 Kichijoji Kitamachi, Musashino City, Tokyo

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 下記式(I) で示されるデ−N-アセチルG
2 及びその塩。 【化1】
1. De-N-acetyl G represented by the following formula (I):
M 2 and its salts. [Chemical 1]
【請求項2】 下記の一般式 (II) で示される、請求項
1記載のデ−N-アセチルGM2 製造中間体: 【化2】 (式中、R1 はアミノ基または保護されたアミノ基を示
し、R2 は水素原子又は低級アルキル基を示し、Xは水
酸基、保護基を有する水酸基、ハロゲン原子、-OCNHCCl
3 、又は下記式: 【化3】 (式中、R3 は水素原子又は水酸基の保護基を示す)で
示される基であり、Pivはピバロイル基を示す)。
2. An intermediate for producing de-N-acetyl GM 2 according to claim 1, which is represented by the following general formula (II): (In the formula, R 1 represents an amino group or a protected amino group, R 2 represents a hydrogen atom or a lower alkyl group, X represents a hydroxyl group, a hydroxyl group having a protective group, a halogen atom, -OCNHCCl
3 or the following formula: (In the formula, R 3 represents a hydrogen atom or a hydroxyl-protecting group), and Piv represents a pivaloyl group).
【請求項3】 下記の一般式 (III)で示される、請求項
1記載のデ−N-アセチルGM2 製造中間体: 【化4】 (式中、R4 はアミノ基又は保護されたアミノ基を示
し、R5 は水素原子又は低級アルキル基を示し、R6
独立に水酸基の保護基を示し、R7 はアミノ基、保護さ
れたアミノ基、またはアジド基を示し、Piv はピバロイ
ル基を示す)。
3. An intermediate for the production of de-N-acetyl GM 2 according to claim 1, which is represented by the following general formula (III): (In the formula, R 4 represents an amino group or a protected amino group, R 5 represents a hydrogen atom or a lower alkyl group, R 6 independently represents a hydroxyl protecting group, and R 7 represents an amino group or a protected group. Represents an amino group or an azido group, and Piv represents a pivaloyl group).
【請求項4】 下記の一般式 (IV) で示される、請求項
1記載のデ−N-アセチルGM2 製造中間体: 【化5】 (式中、R8 はアミノ基又は保護されたアミノ基を示
し、R9 は水素原子又は低級アルキル基を示し、R10
水素原子または水酸基の保護基を示し、R11は独立に水
酸基の保護基を示し、Piv はピバロイル基を示す)。
4. An intermediate for producing de-N-acetyl GM 2 according to claim 1, which is represented by the following general formula (IV): (In the formula, R 8 represents an amino group or a protected amino group, R 9 represents a hydrogen atom or a lower alkyl group, R 10 represents a hydrogen atom or a hydroxyl-protecting group, and R 11 independently represents a hydroxyl group. Represents a protecting group, Piv represents a pivaloyl group).
JP4173148A 1992-06-30 1992-06-30 De-n-acetyl gm2 Pending JPH0616689A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4173148A JPH0616689A (en) 1992-06-30 1992-06-30 De-n-acetyl gm2

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4173148A JPH0616689A (en) 1992-06-30 1992-06-30 De-n-acetyl gm2

Publications (1)

Publication Number Publication Date
JPH0616689A true JPH0616689A (en) 1994-01-25

Family

ID=15954998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4173148A Pending JPH0616689A (en) 1992-06-30 1992-06-30 De-n-acetyl gm2

Country Status (1)

Country Link
JP (1) JPH0616689A (en)

Similar Documents

Publication Publication Date Title
JPH0899989A (en) New glycolipid derivative and intermediate for its production
JPH0193562A (en) Production of sphingosine derivative
JPH0138798B2 (en)
JPS6345293A (en) Sialosylceramide compound and production thereof
EP0728763B1 (en) Ganglioside gm3 analog having sialic acid residue fluorinated at the 9-position and intermediate therefor
Nanami et al. Stereoselective synthesis of various α-selenoglycosides using in situ production of α-selenolate anion
JPH0249795A (en) Novel production process for gangliosides
JPH0616689A (en) De-n-acetyl gm2
AU2013340901A2 (en) Method of preparation of alpha-galactosyl ceramides compounds
Amin et al. Synthesis of asparagine-linked bacillosamine
JPH0616692A (en) New sugar derivative
JPH0684367B2 (en) New method for producing forskolin derivative
Loukou et al. Synthesis of sugar-lactams from azides of glucuronic acid
JPS61282390A (en) S-neuraminic acid derivative
JP4813838B2 (en) O-linked sugar amino acid derivative having core 6 type structure and method for producing the same
JP2581029B2 (en) Novel method for producing sialic acid derivatives
JP2000219696A (en) Sulfonated oligosaccharide compound and its intermediate
JPS62129292A (en) Lipid a monosaccharide related substance developing biological activity
JPH07304789A (en) Method for producing glycero glucolipid compound
JP3163358B2 (en) Sulfated oligosaccharide compounds
Misra et al. Synthesis of the Immunodominant Trisaccharide Related to the Antigen From E. COLI O 126
JP2020158489A (en) Method for Producing Bicyclic Ulosonic Acid Derivative and Method for Producing Ulosonic Acid Derivative
JPH02209885A (en) Sialosylglycerolipid bound with amide linkage
JP2000143686A (en) Sulfated oligosaccharide compound
JPH10298193A (en) Sulfated oligosaccharide compound, its intermediate and production of sulfated oligosaccharide compound